
 
 
 
 
 
 
 
 
 
   具有屍胺生產力之微生物及使用該微生物製造屍胺之方法
 Microorganism with cadaveric amine productivity and method for producing cadaverine using the same
 
 
 
 
   本發明係關於用於製造二胺之微生物及使用該微生物製造二胺之方法。
 The present invention relates to a microorganism for producing a diamine and a method of producing a diamine using the microorganism.
 
 
 
 
 
   生源胺(BA)為含氮化合物，其主要藉由胺基酸之去羧基作用(decarboxylation)或藉由醛及酮之胺化作用及轉胺作用而製造。此等生源胺為低分子量化合物且在微生物、植物及動物之代謝中合成，且因此已知生源胺為頻繁發現於此等細胞中之組分。詳言之，生源胺為多胺，諸如精三胺(spermidine)、精胺(spermine)、腐胺(putrescine)或1,4-丁二胺及屍胺(cadaverine)。
 The living amine (BA) is a nitrogen-containing compound which is mainly produced by decarboxylation of an amino acid or by amination of an aldehyde and a ketone and transamination. These biogenic amines are low molecular weight compounds and are synthesized in the metabolism of microorganisms, plants and animals, and thus biogenic amines are known to be components frequently found in such cells. In particular, the biogenic amine is a polyamine such as spermidine, spermine, putrescine or 1,4-butanediamine and cadaverine.
 
 
 
   一般而言，腐胺為用於製造多胺耐綸-4,6之重要原料，多胺耐綸-4,6藉由使腐胺與己二酸反應而製造。腐胺通常藉由涉及將丙烯轉化為丙烯腈及丁二腈之化學合成而製造。
 In general, putrescine is an important raw material for the manufacture of polyamine nylon-4,6, and polyamine nylon-4,6 is produced by reacting putrescine with adipic acid. Putrescine is typically produced by chemical synthesis involving the conversion of propylene to acrylonitrile and succinonitrile.
 
 
 
   作為使用微生物之腐胺之製造方法，已報導藉由大腸桿菌及棒狀桿菌之轉型來製造高濃度的腐胺之方法(國際專利公開案第WO06/005603號；國際專利公開案第
WO09/125924號；Qian ZD等人，Biotechnol.Bioeng.104：4,651-662,2009；Schneider等人，Appl.Microbiol.Biotechnol.88：4,859-868,2010；Schneider等人，Appl.Microbiol.Biotechnol.95,169-178.,2012)。此外，已經積極地對大腸桿菌、酵母、植物及動物細胞中的腐胺轉運蛋白(transporter)進行了研究(K Igarashi,Plant Physiol.Biochem.48：506-512,2010)。
 As a method for producing a putrescine using a microorganism, a method for producing a high concentration of putrescine by transformation of Escherichia coli and Corynebacterium has been reported (International Patent Publication No. WO06/005603; International Patent Publication No.
WO09/125924; Qian ZD et al, Biotechnol. Bioeng. 104: 4, 651-662, 2009; Schneider et al, Appl. Microbiol. Biotechnol. 88: 4, 859-868, 2010; Schneider et al, Appl. Microbiol. Biotechnol. 95, 169-178., 2012). In addition, putrescine transporters in Escherichia coli, yeast, plant and animal cells have been actively studied (K Igarashi, Plant Physiol. Biochem. 48: 506-512, 2010).
 
 
 
   同時，屍胺為在動物組織的腐化期間藉由蛋白水解製造具臭味的二胺化合物。屍胺具有化學式NH 2 (CH 2 ) 5 NH 2 ，其類似於腐胺的化學式。
 Meanwhile, cadaverine is an odorous diamine compound produced by proteolysis during the decay of animal tissues. The cadaverine has the chemical formula NH  2  (CH  2  )  5  NH  2  , which is similar to the chemical formula of putrescine. 
 
 
   屍胺用作諸如聚醯胺或聚胺基甲酸酯、螯合劑或其他添加劑之聚合物的組分。詳言之，已知具有3.5百萬噸的每年全球市場的聚醯胺藉由屍胺或丁二酸之聚縮合作用而製備，且因此屍胺作為工業上適用之化合物已受到大量關注。
 Cadaverine is used as a component of polymers such as polyamine or polyurethanes, chelating agents or other additives. In particular, polyamines having an annual global market of 3.5 million tons are known to be prepared by polycondensation of cadaverine or succinic acid, and thus cadaverine has received much attention as an industrially applicable compound.
 
 
 
   屍胺為發現於一些微生物中之二胺(Tabor及Tabor,MicrobiolRev.,49：81-99,1985)。在革蘭氏陰性細菌大腸桿菌中，屍胺藉由L-離胺酸去羧酶由L-離胺酸而生物合成。大腸桿菌中屍胺之含量藉由屍胺之生物合成、降解作用、攝取及輸出而調節(Soksawatmaekhin等人，MolMicrobiol.,51：1401-1412,2004)。
 Cadaverine is a diamine found in some microorganisms (Tabor and Tabor, Microbiol Rev., 49: 81-99, 1985). In Gram-negative bacterial E. coli, cadaverine is biosynthesized from L-isoamine by L-isoamine decarboxylase. The content of cadaverine in E. coli is regulated by biosynthesis, degradation, uptake and export of cadaverine (Soksawatmaekhin et al., Mol Microbiol., 51: 1401-1412, 2004).
 
 
 
 
 
 
   本發明的發明人已集中精力研究具有輸出諸如腐胺或
屍胺之二胺的能力以便改良具有二胺生產力的微生物中之二胺生產力之蛋白。結果，其發現溶血隱秘桿菌( Arcanobacterium haemolyticum )源性蛋白或與之具有高胺基酸序列同源性之蛋白具有二胺輸出活性，且此蛋白被引入用於製造二胺之微生物中以增強其活性，導致輸出諸如腐胺及屍胺之二胺的能力顯著增加，藉此完成本發明。
 The inventors of the present invention have concentrated on studying proteins having the ability to output a diamine such as putrescine or cadaverine in order to improve the productivity of diamine in microorganisms having diamine productivity. As a result, it was found that an  Arcanobacterium haemolyticum-  derived protein or a protein having homologous amino acid sequence homology has a diamine exporting activity, and this protein is introduced into a microorganism for producing a diamine to enhance its The activity, resulting in a significant increase in the ability to output diamines such as putrescine and cadaverine, thereby completing the present invention. 
 
 
 
 
   本發明之一目的係提供一種用於製造二胺之微生物。
 One object of the present invention is to provide a microorganism for producing a diamine.
 
 
 
   本發明之另一目的係提供一種製造二胺之方法，其包括以下步驟：(i)培養用於製造二胺之微生物以獲得細胞培養物；及(ii)自經培養之微生物或細胞培養物回收二胺。
 Another object of the present invention is to provide a process for producing a diamine comprising the steps of: (i) cultivating a microorganism for producing a diamine to obtain a cell culture; and (ii) self-cultivating microorganism or cell culture The diamine is recovered.
 
 
 
   [最佳模式]
 [Best mode]
 
 
 
   在實現以上目標之一態樣中，本發明提供一種用於製造二胺之微生物，其中經引人或增強具有SEQ ID NO：6的胺基酸序列或具有42%或更高之與SEQ ID NO：6的序列同源性之胺基酸序列的蛋白之活性。
 In one aspect of achieving the above object, the present invention provides a microorganism for producing a diamine, wherein the amino acid sequence having SEQ ID NO: 6 is introduced or enhanced or has a SEQ ID of 42% or higher The activity of the protein of the amino acid sequence of sequence homology of NO: 6.
 
 
 
   如本文所用，術語「二胺」共同地指具有兩個胺基之化合物，且其特定實例可包括腐胺及屍胺。腐胺為四亞甲基二胺，其可由作為前驅體(precursor)之鳥胺酸而製造。屍胺稱作1,5-戊二胺或五亞甲基二胺，其可由作為前驅體之離胺酸而製造。該等二胺為工業上適用的化合物，其用作合成諸如多胺耐綸、聚醯胺或聚胺基甲酸酯之聚合物的有價值原料。
 As used herein, the term "diamine" collectively refers to a compound having two amine groups, and specific examples thereof may include putrescine and cadaverine. The putrescine is tetramethylenediamine, which can be produced from ornithine as a precursor. The cadaverine is referred to as 1,5-pentanediamine or pentamethylenediamine, which can be produced from an amino acid as a precursor. These diamines are industrially suitable compounds which are useful as starting materials for the synthesis of polymers such as polyamine nylons, polyamides or polyurethanes.
 
 
 
   如本文所用，術語「具有SEQ ID NO：6的胺基酸序列
之蛋白」為發現於溶血隱秘桿菌中之蛋白，且亦稱作ARCH_0271。已研究發現，此蛋白保留與棒狀桿菌之膜蛋白NCgl2522的高同源性。在本發明之一實施例中，ARCH_0271蛋白經鑒定為假定蛋白(putative protein)，其涉及於具有二胺生產力之菌株中的二胺輸出，藉此顯著增加二胺生產力。
 As used herein, the term "amino acid sequence having SEQ ID NO: 6
Protein is a protein found in hemolytic bacterium, also known as ARCH_0271. It has been found that this protein retains high homology with the membrane protein NCgl2522 of Corynebacterium. In one embodiment of the invention, the ARCH_0271 protein is identified as a putative protein that is involved in diamine output in strains having diamine productivity, thereby significantly increasing diamine productivity.
 
 
 
   此處，具有SEQ ID NO：6的胺基酸序列之ARCH_0271蛋白可為由SEQ ID NO：5或SEQ ID NO：7的核苷酸序列編碼之蛋白。然而，在編碼ARCH_0271蛋白之聚核苷酸中，可在編碼區中產生各種修飾，限制條件在於其不改變自該編碼區表現之多肽的胺基酸序列，此係歸因於密碼子簡併性(codon degeneracy)或考慮到其中欲表現該蛋白之生物體所偏好的密碼子。因此，CE2495蛋白可由各種核苷酸序列以及由SEQ ID NO：5或SEQ ID NO：7的核苷酸序列編碼。其中，由SEQ ID NO：7表示的核苷酸序列為藉由針對麩胺酸棒狀桿菌( Corynebacterium glutamicum )之密碼子用法最佳化ARCH_0271基因(SEQ ID NO：5)所製備的序列，但不限於此。
 Here, the ARCH_0271 protein having the amino acid sequence of SEQ ID NO: 6 may be a protein encoded by the nucleotide sequence of SEQ ID NO: 5 or SEQ ID NO: 7. However, in the polynucleotide encoding the ARCH_0271 protein, various modifications can be made in the coding region, with the proviso that it does not alter the amino acid sequence of the polypeptide expressed from the coding region, due to codon degeneracy. Codon degeneracy or codons that are preferred by the organism in which the protein is to be expressed. Thus, the CE2495 protein can be encoded by various nucleotide sequences as well as by the nucleotide sequence of SEQ ID NO: 5 or SEQ ID NO: 7. Wherein the nucleotide sequence represented by SEQ ID NO: 7 is a sequence prepared by optimizing the ARCH_0271 gene (SEQ ID NO: 5) for codon usage of  Corynebacterium glutamicum  , but Not limited to this. 
 
 
   此外，本發明之ARCH_0271蛋白可為具有SEQ ID NO：6的胺基酸序列或具有40%或更高、較佳地60%或更高、更佳地80%或更高、更佳地90%或更高、甚至更佳地95%或更高且最佳地99%或更高的與之同源性之胺基酸序列的任何蛋白，只要該蛋白呈現實質性二胺輸出活性。顯然，其中一部分刪除、經修飾、經取代或經添加之具有該同源
性之胺基酸序列亦在本發明的範圍內，只要所得胺基酸序列具有實質上等於或對應於SEQ ID NO：6之蛋白的生物活性。
 Further, the ARCH_0271 protein of the present invention may be an amino acid sequence having SEQ ID NO: 6 or have 40% or more, preferably 60% or more, more preferably 80% or more, more preferably 90. Any protein of amino acid sequence of % or higher, even more preferably 95% or higher and optimally 99% or higher, as long as the protein exhibits substantial diamine export activity. Obviously, some of them are deleted, modified, substituted or added to have the same homology.
Amino acid sequences are also within the scope of the invention so long as the resulting amino acid sequence has a biological activity substantially equal to or corresponding to the protein of SEQ ID NO: 6.
 
 
 
   如本文所用，術語「具有42%或更高之與SEQ ID NO：6之胺基酸序列的序列同源性之胺基酸序列的蛋白」意謂任何蛋白而無限制，只要該蛋白具有42%或更高之與SEQ ID NO：6的胺基酸序列之序列同源性之胺基酸序列且其亦實質上具有二胺輸出活性即可。例如，該蛋白可為具有SEQ ID NO：23或SEQ ID NO：26的胺基酸序列之蛋白，但不限於此。
 As used herein, the term "protein having an amino acid sequence of sequence homology to the amino acid sequence of SEQ ID NO: 6 of 42% or higher" means any protein without limitation as long as the protein has 42 The amino acid sequence of % or higher of sequence homology to the amino acid sequence of SEQ ID NO: 6 and which also has substantially diamine export activity. For example, the protein may be a protein having the amino acid sequence of SEQ ID NO: 23 or SEQ ID NO: 26, but is not limited thereto.
 
 
 
   例如，具有SEQ ID NO：23的胺基酸序列之蛋白為發現於糞產鹼菌糞亞種( Alcaligenes faecalis  subsp.faecalis)中之蛋白，且亦稱作QWA_00075。已研究發現，此蛋白保留與棒狀桿菌之膜蛋白NCgl2522的41%同源性及與溶血隱秘桿菌之ARCH_0271的42%同源性。在本發明之一實施例中，已研究發現QWA_00075蛋白在具有二胺生產力之菌株中呈現二胺輸出活性，藉此顯著增加二胺生產力。
 For example, the protein having the amino acid sequence of SEQ ID NO: 23 is a protein found in  Alcaligenes faecalis  subsp.  faecalis  , and is also referred to as QWA_00075. It has been found that this protein retains 41% homology with the membrane protein NCgl2522 of Corynebacterium and 42% homology with ARCH_0271 of C. hemolyticum. In one embodiment of the invention, it has been discovered that the QWA_00075 protein exhibits diamine export activity in strains having diamine productivity, thereby significantly increasing diamine productivity. 
 
 
   具有SEQ ID NO：23的胺基酸序列之QWA_00075蛋白可為由SEQ ID NO：22或SEQ ID NO：24的核苷酸序列編碼之蛋白。然而，在編碼此蛋白之聚核苷酸中，可在編碼區中產生各種修飾，限制條件在於其不改變自該編碼區表現之多肽的胺基酸序列，此係歸因於密碼子簡併性或考慮到其中欲表現該蛋白之生物體所偏好的密碼子。因此，此蛋白可由各種核苷酸序列以及由SEQ ID NO：22或SEQ 
ID NO：24的核苷酸序列編碼。其中，由SEQ ID NO：24表示的核苷酸序列為藉由針對麩胺酸棒狀桿菌之密碼子用法最佳化QWA_00075基因(SEQ ID NO：22)所製備的序列，但不限於此。
 The QWA_00075 protein having the amino acid sequence of SEQ ID NO: 23 may be a protein encoded by the nucleotide sequence of SEQ ID NO: 22 or SEQ ID NO: 24. However, in the polynucleotide encoding this protein, various modifications can be made in the coding region, with the proviso that it does not alter the amino acid sequence of the polypeptide expressed from the coding region, due to codon degeneracy. Sex or take into account the codons preferred by the organism in which the protein is to be expressed. Thus, this protein can be composed of various nucleotide sequences as well as by SEQ ID NO: 22 or SEQ
ID NO: The nucleotide sequence of 24 is encoded. Here, the nucleotide sequence represented by SEQ ID NO: 24 is a sequence prepared by optimizing the QWA_00075 gene (SEQ ID NO: 22) for codon usage of Corynebacterium glutamicum, but is not limited thereto.
 
 
 
   此外，具有SEQ ID NO：26的胺基酸序列之蛋白為發現於嗜麥芽寡養單胞菌( Stenotrophomonas maltophilia )中之蛋白，且亦稱作SMD_2351。已研究發現，此蛋白保留與棒狀桿菌之膜蛋白NCgl2522的52%同源性及與溶血隱秘桿菌之ARCH_0271的47%同源性。在本發明之一實施例中，已研究發現SMD_2351蛋白在具有二胺生產力之菌株中呈現二胺輸出活性，藉此顯著增加二胺生產力。
 In addition, having the SEQ ID NO: 26 is the amino acid sequence of the protein is found in Stenotrophomonas maltophilia strain  (Stenotrophomonas maltophilia)  of the protein, called Qieyi SMD_2351. It has been found that this protein retains 52% homology with the membrane protein NCgl2522 of Corynebacterium and 47% homology with ARCH_0271 of C. hemolyticum. In one embodiment of the invention, it has been discovered that the SMD 2351 protein exhibits diamine export activity in strains having diamine productivity, thereby significantly increasing diamine productivity. 
 
 
   具有SEQ ID NO：26的胺基酸序列之SMD_2351蛋白可為由SEQ ID NO：25或SEQ ID NO：27的核苷酸序列編碼之蛋白。然而，在編碼此蛋白之聚核苷酸中，可在編碼區中產生各種修飾，限制條件在於其不改變自該編碼區表現之多肽的胺基酸序列，此係歸因於密碼子簡併性或考慮到其中欲表現該蛋白之生物體所偏好的密碼子。因此，此蛋白可由各種核苷酸序列以及由SEQ ID NO：25或SEQ ID NO：27的核苷酸序列編碼。其中，由SEQ ID NO：27表示的核苷酸序列為藉由針對麩胺酸棒狀桿菌之密碼子用法最佳化SMD_2351基因(SEQ ID NO：25)所製備的序列，但不限於此。
 The SMD-2351 protein having the amino acid sequence of SEQ ID NO: 26 may be a protein encoded by the nucleotide sequence of SEQ ID NO: 25 or SEQ ID NO: 27. However, in the polynucleotide encoding this protein, various modifications can be made in the coding region, with the proviso that it does not alter the amino acid sequence of the polypeptide expressed from the coding region, due to codon degeneracy. Sex or take into account the codons preferred by the organism in which the protein is to be expressed. Thus, this protein can be encoded by various nucleotide sequences as well as by the nucleotide sequence of SEQ ID NO: 25 or SEQ ID NO: 27. Here, the nucleotide sequence represented by SEQ ID NO: 27 is a sequence prepared by optimizing the SMD_2351 gene (SEQ ID NO: 25) for codon usage of Corynebacterium glutamicum, but is not limited thereto.
 
 
 
   如本文關於序列所用的術語「同源性」係指與給定胺基酸序列或核苷酸序列之同一性，且同源性可以百分比表
述。在本發明中，具有與給定胺基酸序列或核苷酸序列同一或相似之活性的同源性序列係以「同源性%」表述。例如，同源性可使用計算評分、同一性及相似性之參數的標準軟體程式，特定言之BLAST 2.0或藉由在南方(Southern)雜交實驗中在所定義之嚴格條件下比較序列來鑒別。定義適當雜交條件係在此項技術之技能內(例如參見Sambrook等人，1989，下文)，且藉由熟習此項技術者已知之方法確定。
 The term "homology" as used herein with respect to a sequence refers to the identity to a given amino acid sequence or nucleotide sequence, and the percent homology can be expressed as a percentage table.
Said. In the present invention, a homologous sequence having an activity identical or similar to a given amino acid sequence or nucleotide sequence is expressed as "% homology". For example, homology can be identified using standard software programs that calculate parameters of scoring, identity, and similarity, specifically BLAST 2.0, or by comparing sequences under stringent conditions as defined in a Southern hybridization experiment. Defining appropriate hybridization conditions is within the skill of the art (see, for example, Sambrook et al., 1989, hereinafter) and is determined by methods known to those skilled in the art.
 
 
 
   如本文所用，術語「用於製造二胺之微生物」係指藉由對不具有二胺生產力之親本菌株(parent strain)提供二胺生產力所製備的微生物或具有內源二胺生產力之微生物。特定言之，具有二胺生產力之微生物可為具有腐胺或屍胺生產力之微生物。
 As used herein, the term "microorganism for producing a diamine" refers to a microorganism prepared by providing diamine productivity to a parent strain having no diamine productivity or a microorganism having endogenous diamine productivity. In particular, the microorganism having diamine productivity may be a microorganism having putrescine or cadaveric productivity.
 
 
 
   「具有腐胺生產力之微生物」可為但不限於將麩胺酸轉化為N-乙醯基麩胺酸之乙醯基麩胺酸合成酶、將乙醯基鳥胺酸轉化為鳥胺酸之鳥胺酸乙醯基轉移酶(ArgJ)、將乙醯基麩胺酸轉化為N-乙醯基麩胺醯基磷酸之乙醯基麩胺酸激酶(ArgB)、將乙醯基麩胺醯基磷酸轉化為N-乙醯基麩胺酸半醛之乙醯基-γ-麩胺醯基-磷酸還原酶(ArgC)或將乙醯基麩胺酸半醛轉化為N-乙醯基鳥胺酸之乙醯基鳥胺酸胺基轉移酶(ArgD)的活性與其內源活性相比有所增強，以便增強自麩胺酸至鳥胺酸之生物合成路徑，且用作腐胺生物合成之前驅體的鳥胺酸之生產力有所增強的微生物，但不限於此。
 "Microorganisms with putrescine productivity" can be, but are not limited to, ethyl glutamic acid synthase which converts glutamic acid to N-ethyl glutamic acid, and converts acetaminol acinidic acid to ornithine Orthopteryl transferase (ArgJ), ethyl glutamic acid kinase (ArgB) which converts ethyl glutamic acid to N-ethyl glutamic acid thioglycolic acid, bismuth glutamine Conversion of phosphatidyl phosphate to N-ethyl glutamic acid semialdehyde, ethionyl-gamma- glutamic acid thiol-phosphate reductase (ArgC) or conversion of acetamino glutamic acid semialdehyde to N-acetyl guanidine The activity of the amino acid acetamidoguanylamine transferase (ArgD) is enhanced compared to its endogenous activity to enhance the biosynthetic pathway from glutamic acid to ornithine and is used as putrescine biosynthesis Microorganisms in which the productivity of ornithine in the precursor is enhanced, but are not limited thereto.
 
 
 
   此外，具有腐胺生產力之微生物可為經修飾以具有比其內源活性弱的自鳥胺酸合成精胺酸所涉及之鳥胺酸胺甲醯基轉移酶(ArgF)、麩胺酸輸出所涉及之蛋白(NCgl1221)及/或腐胺乙醯化所涉及之蛋白(NCgl469)的活性，及/或經修飾以引入鳥胺酸去羧酶(ODC)的活性之微生物。
 In addition, the microorganism having putrescine productivity may be an ornithine amine-mercaptotransferase (ArgF) or a glutamic acid exporter which is modified to have a weaker than its endogenous activity to synthesize arginine from ursolic acid. The activity of the protein involved (NCgl1221) and/or the protein involved in putrescine (NCgl469), and/or the microorganism modified to introduce the activity of ornithine decarboxylase (ODC).
 
 
 
   此處，作為非限制性實例，乙醯基-γ-麩胺醯基磷酸還原酶(ArgC)可具有SEQ ID NO：15的胺基酸序列，乙醯基麩胺酸合成酶或鳥胺酸乙醯基轉移酶(ArgJ)可具有SEQ ID NO：16的胺基酸序列，乙醯基麩胺酸激酶(ArgB)可具有SEQ ID NO：17的胺基酸序列，且乙醯基鳥胺酸胺基轉移酶(ArgD)可具有SEQ ID NO：18的胺基酸序列。然而，個別酶蛋白的胺基酸序列並未特定受限於此，且該等酶可為具有80%或更高、較佳地90%或更高或更佳地95%或更高的與之同源性的胺基酸序列之蛋白，只要其具有該等個別酶之活性。
 Here, as a non-limiting example, ethionyl-γ-glutaminylphosphoryl reductase (ArgC) may have the amino acid sequence of SEQ ID NO: 15, acetamido glutamate synthase or ornithine The acetyltransferase (ArgJ) may have the amino acid sequence of SEQ ID NO: 16, and the ethionyl glutamate kinase (ArgB) may have the amino acid sequence of SEQ ID NO: 17, and acetamidoguanine The acid aminotransferase (ArgD) may have the amino acid sequence of SEQ ID NO: 18. However, the amino acid sequences of the individual enzyme proteins are not particularly limited thereto, and the enzymes may be 80% or higher, preferably 90% or higher, or more preferably 95% or higher. A protein of a homologous amino acid sequence as long as it has the activity of the individual enzymes.
 
 
 
   此外，作為非限制性實例，鳥胺酸胺甲醯基轉移酶(ArgF)可具有由SEQ ID NO：19表示之胺基酸序列，麩胺酸輸出所涉及之蛋白可具有由SEQ ID NO：20表示之胺基酸序列，且鳥胺酸去羧酶(ODC)可具有由SEQ ID NO：21表示之胺基酸序列。然而，個別酶蛋白的胺基酸序列並未特定受限於此，且該等酶可包括具有80%或更高、較佳地90%或更高、更佳地95%或更高或尤其較佳地97%或更高的與之同源性的胺基酸序列，只要其具有該等個別酶之活性。
 Further, as a non-limiting example, the ornithine amine-mercaptotransferase (ArgF) may have the amino acid sequence represented by SEQ ID NO: 19, and the protein involved in the glutamic acid export may have the SEQ ID NO: The amino acid sequence represented by 20, and the alanine decarboxylase (ODC) may have the amino acid sequence represented by SEQ ID NO:21. However, the amino acid sequences of the individual enzyme proteins are not particularly limited thereto, and the enzymes may include 80% or more, preferably 90% or more, more preferably 95% or more, or especially Preferably, 97% or more of the amino acid sequence homologous thereto is as long as it has the activity of the individual enzymes.
 
 
 
   同時，「具有屍胺生產力之微生物」可為但不限於藉由在具有離胺酸生產力之微生物中另外引入或增強離胺酸去羧酶(LDC)的活性而製備之微生物。例如，該微生物可為具有增強之離胺酸生產力以便增加屍胺產生之微生物。增強離胺酸生產力之方法可藉由熟習此項技術者可預知之已知方法執行。
 Meanwhile, the "microorganism having cadaveric amine productivity" may be, but not limited to, a microorganism prepared by additionally introducing or enhancing the activity of lysine decarboxylase (LDC) in a microorganism having a salicylic acid productivity. For example, the microorganism can be a microorganism having enhanced lysine productivity to increase cadaverine production. Methods of enhancing lysine productivity can be performed by known methods known to those skilled in the art.
 
 
 
   離胺酸去羧酶為催化離胺酸轉化為屍胺之酶，且其活性經引入或增強，藉此有效地產生屍胺。
 The lysine decarboxylase is an enzyme that catalyzes the conversion of lysine to cadaverine, and its activity is introduced or enhanced, thereby efficiently producing cadaverine.
 
 
 
   離胺酸去羧酶可具有SEQ ID NO：33的胺基酸序列，但未特定受限於此。該酶可具有80%或更高、較佳地90%或更高或更佳地95%或更高的與之同源性之胺基酸序列，只要其具有以上活性。
 The lysine decarboxylase may have the amino acid sequence of SEQ ID NO: 33, but is not specifically limited thereto. The enzyme may have an amino acid sequence of 80% or more, preferably 90% or more or more preferably 95% or more homologous as long as it has the above activity.
 
 
 
   如本文所用，術語「產生」為包括二胺之細胞外釋放(例如二胺釋放至培養基中)以及微生物內二胺之產生的概念。
 As used herein, the term "produce" is intended to include the concept of extracellular release of a diamine (eg, release of a diamine into a culture medium) and the production of a diamine within a microorganism.
 
 
 
   同時，如本文所用之術語「蛋白活性之引入」意謂不具有內源蛋白之微生物由外部提供該蛋白之活性，且例如，其可藉由引入外源基因來執行。此外，術語「蛋白活性之增強」意謂保留於或引入微生物中之蛋白的活性狀態與其固有活性狀態相比有所增強。
 Meanwhile, the term "introduction of protein activity" as used herein means that a microorganism having no endogenous protein provides activity of the protein externally, and for example, it can be performed by introducing a foreign gene. Further, the term "enhancement of protein activity" means that the activity state of a protein retained or introduced into a microorganism is enhanced as compared with its intrinsic activity state.
 
 
 
   蛋白活性之引入或增強之非限制性實例可包括存在於微生物中的蛋白自身之活性由於突變而改良以便實現超出內源功能之效果，及/或存在於微生物中的蛋白之內源基因活性的改良、內源基因由內部或外部因子擴增、基因複本
數增加、藉由外源基因之額外引入或啟動子之置換或修飾增加活性，但不限於此。
 Non-limiting examples of introduction or enhancement of protein activity may include that the activity of the protein itself present in the microorganism is modified by mutation to achieve an effect beyond the endogenous function, and/or the endogenous gene activity of the protein present in the microorganism. Improved, endogenous gene amplified by internal or external factors, gene copies
The number is increased, the activity is increased by the additional introduction of a foreign gene or the substitution or modification of the promoter, but is not limited thereto.
 
 
 
   基因複本數增加可(但不特定限於)藉由將該基因可操作性連接於載體或藉由將其整合至宿主細胞基因組中來執行。特定言之，宿主細胞基因組中之聚核苷酸之複本數可藉由在宿主細胞中引入可操作性連接於編碼本發明蛋白之聚核苷酸且獨立於宿主細胞進行複製且起作用的載體，或藉由在宿主細胞中引入可操作性連接於該聚核苷酸且能夠將該聚核苷酸整合至宿主細胞基因組中之載體而增加。
 An increase in the number of gene copies can be, but is not particularly limited to, be performed by operably linking the gene to a vector or by integrating it into the host cell genome. In particular, the number of copies of a polynucleotide in a host cell genome can be achieved by introducing into a host cell a vector operably linked to a polynucleotide encoding a protein of the invention and replicating and functioning independently of the host cell. Or increased by introducing into a host cell a vector operably linked to the polynucleotide and capable of integrating the polynucleotide into the host cell genome.
 
 
 
   如本文所用，「用於增加聚核苷酸表現之表現調節序列的修飾」可(但不特定限於)藉由經由核苷酸序列之刪除、插入、非保守性或保守性取代或其組合誘導表現調節序列上的修飾以便進一步增強表現調節序列之活性，或藉由用具有較強活性之核苷酸序列置換表現調節序列來進行。表現調節序列包括(但不特定限於)啟動子、操作子序列、編碼核糖體結合位點之序列及調節轉錄及轉譯之終止的序列。
 As used herein, "modifications for increasing the expression regulatory sequences of a polynucleotide display" can be, but are not particularly limited to, induced by deletion, insertion, non-conservative or conservative substitution of a nucleotide sequence, or a combination thereof. Modifications in the regulatory sequences are performed to further enhance the activity of the expression regulatory sequences, or by replacing the expression regulatory sequences with a more active nucleotide sequence. Expression regulatory sequences include, but are not particularly limited to, promoters, operator sequences, sequences encoding ribosome binding sites, and sequences that regulate termination of transcription and translation.
 
 
 
   如本文所用，啟動子之置換或修飾(儘管未特定受限於此)可藉由用比初始啟動子強之啟動子進行置換或修飾來執行。替代初始啟動子之強異源啟動子可連接於聚核苷酸表現單元的上游，且強啟動子之實例可包括CJ7啟動子、lysCP1啟動子、EF-Tu啟動子、groEL啟動子、aceA或aceB啟動子，且特定言之，棒狀桿菌源性啟動子lysCP1啟動子或CJ7啟動子可操作性連接於編碼該酶之聚核苷酸，使得
其表現率可增加。此處，lysCP1啟動子為經由編碼天冬胺酸激酶及天冬胺酸半醛去氫酶之聚核苷酸的啟動子區域之核苷酸序列取代改良的啟動子(WO 2009/096689)。此外，CJ7啟動子為源自產氨短桿菌( Corynebacterium ammoniagenes )之強啟動子(韓國發明專利第0620092號及WO 2006/065095)。
 As used herein, a substitution or modification of a promoter (although not specifically limited thereto) can be performed by substitution or modification with a promoter that is stronger than the original promoter. A strong heterologous promoter that replaces the initial promoter can be ligated upstream of the polynucleotide expression unit, and examples of strong promoters can include the CJ7 promoter, the lysCP1 promoter, the EF-Tu promoter, the groEL promoter, aceA or The aceB promoter, and in particular, the Corynebacterium-derived promoter lysCP1 promoter or CJ7 promoter is operably linked to a polynucleotide encoding the enzyme such that its rate of expression can be increased. Here, the lysCP1 promoter replaces a modified promoter with a nucleotide sequence of a promoter region encoding a polynucleotide of aspartate kinase and aspartate semialdehyde dehydrogenase (WO 2009/096689). Further, the CJ7 promoter is a strong promoter derived from  Corynebacterium ammoniagenes  (Korean invention patent No. 0620092 and WO 2006/065095). 
 
 
   此外，染色體上之聚核苷酸序列的修飾(儘管未特定受限於此)可藉由經由聚核苷酸序列之刪除、插入、非保守性或保守性取代或其組合誘導表現調節序列上的突變以便進一步增強該聚核苷酸序列之活性，或藉由用經修飾以具有較強活性之聚核苷酸序列置換該序列來執行。
 Furthermore, modifications of the polynucleotide sequence on the chromosome (although not specifically limited thereto) can be induced on the expression regulatory sequence by deletion, insertion, non-conservative or conservative substitution of the polynucleotide sequence or a combination thereof. Mutations are made to further enhance the activity of the polynucleotide sequence, or by replacing the sequence with a polynucleotide sequence modified to have greater activity.
 
 
 
   如本文所用，術語「載體」係指包括編碼所需蛋白的核苷酸序列的DNA構築體，其可操作性連接於適當表現調節序列以在合適之宿主細胞中表現所需蛋白。調節序列可包括可起始轉錄之啟動子、用於調節轉錄之視情況存在的操作子序列、編碼合適之mRNA核糖體結合位點的序列及調節轉錄及轉譯的終止之序列。在載體引入至合適之宿主細胞中之後，其可獨立於宿主基因組複製或起作用，且可整合至基因組自身中。
 As used herein, the term "vector" refers to a DNA construct comprising a nucleotide sequence encoding a desired protein operably linked to an appropriately expressed regulatory sequence to express a desired protein in a suitable host cell. Regulatory sequences can include a promoter that initiates transcription, an operator sequence that regulates the presence of transcription, a sequence encoding a suitable mRNA ribosome binding site, and sequences that regulate termination of transcription and translation. After the vector has been introduced into a suitable host cell, it can replicate or function independently of the host genome and can be integrated into the genome itself.
 
 
 
   用於本發明之載體並未受特定限制，只要其能夠在宿主細胞中複製，且此項技術中已知之任何載體均可使用。習知載體之實例可包括天然或重組質體、黏質體、病毒及噬菌體。例如，pWE15、M13、λMBL3、λMBL4、λIXII、λASHII、λAPII、λt10、λt11、Charon4A及Charon21A可
用作噬菌體載體或黏質體載體。pBR類型、pUC類型、pBluescriptII類型、pGEM類型、pTZ類型、pCL類型及pET類型可用作質體載體。適用於本發明之載體並未受特定限制，且任何已知表現載體均可使用。較佳地，可使用pDZ、pACYC177、pACYC184、pCL、pECCG117、pUC19、pBR322、pMW118或pCC1BAC載體。
 The vector used in the present invention is not particularly limited as long as it can replicate in a host cell, and any vector known in the art can be used. Examples of conventional carriers can include natural or recombinant plastids, vesicles, viruses, and phage. For example, pWE15, M13, λMBL3, λMBL4, λIXII, λASHII, λAPII, λt10, λt11, Charon4A, and Charon21A
Used as a phage vector or a viscous carrier. The pBR type, pUC type, pBluescriptII type, pGEM type, pTZ type, pCL type, and pET type can be used as a plastid vector. The carrier suitable for use in the present invention is not particularly limited, and any known expression carrier can be used. Preferably, pDZ, pACYC177, pACYC184, pCL, pECCG117, pUC19, pBR322, pMW118 or pCC1BAC vectors can be used.
 
 
 
   此外，染色體中編碼所需內源蛋白之聚核苷酸可使用用於細菌染色體插入之載體由突變型聚核苷酸置換。該聚核苷酸插入至染色體中可藉由此項技術中已知之任何方法，例如同源重組來執行。由於本發明之載體可藉由同源重組插入至染色體中，其可進一步包括選擇標誌物以確認染色體插入。選擇標誌物將選擇由載體轉型之細胞，亦即確認所需聚核苷酸之插入，且選擇標誌物可包括提供可選擇表型(諸如藥物抗性、營養缺陷型、對細胞毒性劑之抗性或表面蛋白表現)之標誌物。僅表現選擇標誌物之細胞能夠在用該選擇性試劑處理之環境下存活或顯示不同表現，且因此可選擇經轉型細胞。
 Furthermore, a polynucleotide encoding a desired endogenous protein in a chromosome can be replaced with a mutant polynucleotide using a vector for bacterial chromosomal insertion. Insertion of the polynucleotide into the chromosome can be performed by any method known in the art, such as homologous recombination. Since the vector of the present invention can be inserted into a chromosome by homologous recombination, it can further include a selection marker to confirm chromosomal insertion. Selection of the marker will select for cells transformed from the vector, ie, confirmation of insertion of the desired polynucleotide, and selection of the marker may include providing a selectable phenotype (such as drug resistance, auxotrophy, resistance to cytotoxic agents) A marker of sexual or surface protein expression). Cells that only display a selection marker are able to survive or exhibit different performance in an environment treated with the selective agent, and thus can be transformed into cells.
 
 
 
   如本文所用，術語「轉型」意謂包括編碼標靶蛋白之聚核苷酸的載體以使得由該聚核苷酸編碼之蛋白在宿主細胞中表現之方式引入至宿主細胞中。只要經轉型之聚核苷酸可在宿主細胞中表現，其可整合至宿主細胞之染色體中且位於其中，或在染色體外存在。此外，該聚核苷酸包括編碼標靶蛋白之DNA及RNA。該聚核苷酸可以任何形式引入，只要其可引入至宿主細胞中且在其中表現。例如，
該聚核苷酸可以表現卡匣(cassette)之形式引入至宿主細胞中，該表現卡匣為包括其自主表現所需之所有元素的基因構築體。典型地，該表現卡匣包括可操作性連接於該聚核苷酸之啟動子、轉錄終止信號、核糖體結合位點或轉譯終止信號。該表現卡匣可呈可自複製表現載體之形式。又，該聚核苷酸可原樣引入至宿主細胞中且可操作性連接於在宿主細胞中表現所需之序列。
 As used herein, the term "transformation" means a vector comprising a polynucleotide encoding a target protein such that the protein encoded by the polynucleotide is introduced into the host cell in a manner that is expressed in the host cell. As long as the transformed polynucleotide is expressed in a host cell, it can be integrated into and located in the chromosome of the host cell, or be present extrachromosomally. In addition, the polynucleotide includes DNA and RNA encoding a target protein. The polynucleotide may be introduced in any form as long as it can be introduced into and expressed in a host cell. E.g,
The polynucleotide may be introduced into a host cell in the form of a cassette, which is a genetic construct including all of the elements required for its autonomous expression. Typically, the performance cassette comprises a promoter operably linked to the polynucleotide, a transcription termination signal, a ribosome binding site or a translation termination signal. The performance card may be in the form of a self-replicating expression carrier. Further, the polynucleotide can be introduced into the host cell as it is and operably linked to the sequence required for expression in the host cell.
 
 
 
   此外，如本文所用，術語「可操作性連接」意謂在編碼本發明之所需蛋白的聚核苷酸序列與起始且介導該聚核苷酸序列之轉錄的啟動子序列之間的功能連接。
 Further, as used herein, the term "operably linked" means between a polynucleotide sequence encoding a desired protein of the invention and a promoter sequence that initiates and mediates transcription of the polynucleotide sequence. Functional connection.
 
 
 
   此外，具有二胺生產力之微生物可為其中二胺乙醯基轉移酶活性與內源活性相比有所減弱以便增加二胺產生之微生物。
 Further, the microorganism having diamine productivity may be a microorganism in which diamine acetyltransferase activity is weakened compared to endogenous activity to increase diamine production.
 
 
 
   如本文所用，術語「二胺乙醯基轉移酶」為催化乙醯基自乙醯基-CoA轉移至二胺之酶，且其可由麩胺酸棒狀桿菌NCgl1469或大腸桿菌SpeG例示，但其名稱可視具有二胺生產力之微生物的屬而變化。NCgl1469可具有SEQ ID NO：12或SEQ ID NO：13的胺基酸序列，且SpeG可具有SEQ ID NO：14的胺基酸序列，但該序列可視微生物之屬而變化。該蛋白可具有80%或更高、較佳地90%或更高、或更佳地95%或更高或尤其較佳地97%或更高的與之同源性之胺基酸序列，只要其具有二胺乙醯基轉移酶活性。
 As used herein, the term "diamine acetyltransferase" is an enzyme that catalyzes the transfer of ethenyl from ethinyl-CoA to a diamine, and which may be exemplified by Corynebacterium glutamicum NCgl1469 or Escherichia coli SpeG, but The name may vary depending on the genus of the microorganism having diamine productivity. NCgl1469 may have the amino acid sequence of SEQ ID NO: 12 or SEQ ID NO: 13, and SpeG may have the amino acid sequence of SEQ ID NO: 14, but the sequence may vary depending on the genus of the microorganism. The protein may have an amino acid sequence of 80% or higher, preferably 90% or higher, or more preferably 95% or higher, or particularly preferably 97% or higher, homologous thereto. As long as it has diamine acetyltransferase activity.
 
 
 
   由於二胺乙醯基轉移酶將二胺轉化為乙醯基-二胺(例如，N-Ac-腐胺或N-Ac-屍胺)，二胺生產力可藉由與內源
活性相比之下減弱其活性而增加。
 Since diamine acetyltransferase converts a diamine to an ethenyl-diamine (for example, N-Ac-putrescine or N-Ac-cadaverine), diamine productivity can be achieved by endogenous
The activity is increased in comparison to attenuating its activity.
 
 
 
   如本文所用，術語「內源活性」係指初始微生物具有之蛋白呈其原生或未變性狀態的活性，且「經修飾以具有與內源活性相比之下減弱之活性」意謂與初始微生物具有之相應蛋白呈原生或未變性狀態的活性相比蛋白之活性進一步減弱。
 As used herein, the term "endogenous activity" refers to an activity in which the protein of the original microorganism is in its native or undenatured state, and "modified to have an attenuated activity compared to the endogenous activity" means the initial microorganism The activity of the corresponding protein in its native or undenatured state is further attenuated compared to the activity of the protein.
 
 
 
   蛋白活性之減弱意謂與非修飾之菌株相比蛋白活性降低，或活性消除。有可能將此項技術中熟知之方法應用於蛋白活性之減弱。
 A decrease in protein activity means a decrease in protein activity or a elimination of activity compared to a non-modified strain. It is possible to apply methods well known in the art to the attenuation of protein activity.
 
 
 
   該方法之實例可包括由突變以降低酶活性或消除蛋白活性之基因置換染色體上編碼該蛋白之基因的方法；將突變引入至染色體上編碼該蛋白之基因之表現調節序列中的方法；由具有較弱活性之序列置換編碼該蛋白之基因之表現調節序列的方法；使染色體上編碼該蛋白之基因之一部分或全部刪除的方法；引入互補性結合於染色體上該基因之轉錄物之反義寡核苷酸以抑制mRNA轉譯為該蛋白的方法；在編碼該蛋白之基因之SD序列的上游人工添加與SD序列互補的序列以形成二級結構，藉此阻止核糖體次單元之進入的方法；及在相應序列之開放閱讀框(ORF)的3’-端添加用於逆轉錄之啟動子的逆轉錄工程改造(RTE)方法，及其組合，但並未特定受限於此。
 Examples of the method may include a method of replacing a gene encoding a protein on a chromosome by a gene which mutates to reduce enzymatic activity or eliminate protein activity; a method of introducing a mutation into a expression regulating sequence of a gene encoding the protein on a chromosome; a method of replacing a regulatory sequence encoding a gene of the protein with a weaker active sequence; a method of deleting a portion or all of a gene encoding the protein on the chromosome; introducing an antisense oligo that complements the transcript of the gene on the chromosome Nucleotide a method of inhibiting translation of mRNA into the protein; a method of artificially adding a sequence complementary to the SD sequence upstream of the SD sequence encoding the gene to form a secondary structure, thereby preventing entry of the ribosome subunit; And a reverse transcription engineering (RTE) method for the promoter of reverse transcription, and combinations thereof, at the 3'-end of the open reading frame (ORF) of the corresponding sequence, but are not particularly limited thereto.
 
 
 
   詳言之，編碼該蛋白之基因的部分或完全刪除可藉由將用於染色體插入之載體引入至微生物中，藉此用具有部分刪除或標誌物基因之聚核苷酸取代染色體上編碼內源標
靶蛋白之聚核苷酸來進行。「部分」可視聚核苷酸之類型而變化，但特定言之係指1至300個，較佳地1至100個，且更佳地1至50個核苷酸。
 In particular, partial or complete deletion of the gene encoding the protein can be accomplished by introducing a vector for chromosomal insertion into the microorganism, thereby replacing the intrachromosomal coding endogenous with a polynucleotide having a partial deletion or marker gene. Standard
The polynucleotide of the target protein is carried out. The "portion" may vary depending on the type of the polynucleotide, but specifically means 1 to 300, preferably 1 to 100, and more preferably 1 to 50 nucleotides.
 
 
 
   同時，本發明之微生物為具有二胺生產力之微生物，且包括表現具有SEQ ID NO：6的胺基酸序列之蛋白的原核微生物，且其實例可包括屬於埃希氏菌屬( Escherichia  sp.)、志賀氏菌屬( Shigella  sp.)、檸檬酸桿菌屬( Citrobacter  sp.)、沙門氏菌屬( Salmonella  sp.)、腸桿菌屬( Enterobacter  sp.)、耶爾森氏菌屬( Yersinia  sp.)、克氏桿菌屬( Klebsiella  sp.)、歐文氏菌屬( Erwinia  sp.)、棒狀桿菌屬( Corynebacterium  sp.)、短桿菌屬( Brevibacterium  sp.)、乳桿菌屬( Lactobacillus  sp.)、新月單胞菌屬( Selenomanas  sp.)、弧菌屬( Vibrio  sp.)、假單胞菌屬( Pseudomonas  sp.)、鏈黴菌屬( Streptomyces  sp.)、隱秘桿菌屬( Arcanobacterium  sp.)、產鹼桿菌屬( Alcaligenes  sp.)或其類似屬之微生物，但不限於此。本發明之微生物特定言之為屬於棒狀桿菌屬或埃希氏菌屬，且更特定言之麩胺酸棒狀桿菌或大腸桿菌之微生物，但不限於此。
 Meanwhile, the microorganism of the present invention is a microorganism having diamine productivity, and includes a prokaryotic microorganism which exhibits a protein having the amino acid sequence of SEQ ID NO: 6, and examples thereof may include belonging to the genus  Escherichia  sp. ,  Shigella  sp.,  Citrobacter  sp.,  Salmonella  sp.,  Enterobacter  sp.,  Yersinia  sp.,  Klebsiella  sp.,  Erwinia  sp.,  Corynebacterium  sp.,  Brevibacterium  sp.,  Lactobacillus  sp., New Moon  Selenomanas  sp.,  Vibrio  sp.,  Pseudomonas  sp.,  Streptomyces  sp.,  Arcanobacterium  sp., alkali production A microorganism of the genus  Alcaligenes  sp. or the like, but is not limited thereto. The microorganism of the present invention is specifically a microorganism belonging to the genus Corynebacterium or Escherichia, and more specifically, Corynebacterium glutamicum or Escherichia coli, but is not limited thereto. 
 
 
   特定實例可為藉由使基於麩胺酸棒狀桿菌ATCC13032之產腐胺菌株KCCM11240P(韓國發明專利公開案第2013-0082478號)刪除NCgl2522且接著將ARCH_0271引入至轉位子基因中而製備之微生物，NCgl2522為具有腐胺輸出活性之蛋白。因此，此微生物KCCM11240P △NCgl2522 Tn：P(cj7)-ARCH_0271指定為CC01-0758，且在2013年11月15日根據布達佩斯條約以
寄存號KCCM11476P寄存於韓國微生物培養中心(Korean Culture Center of Microorganisms；KCCM)。
 A specific example may be a microorganism prepared by deleting a putrescine strain KCCM11240P (Korean Invention Patent Publication No. 2013-0082478) based on Corynebacterium glutamicum ATCC13032, and then introducing ARCH_0271 into a transposon gene. NCgl2522 is a protein having putrescine export activity. Therefore, this microorganism KCCM11240P △NCgl2522 Tn:P(cj7)-ARCH_0271 is designated as CC01-0758, and according to the Budapest Treaty on November 15, 2013
The registration number KCCM11476P is deposited at the Korean Culture Center of Microorganisms (KCCM).
 
 
 
   在另一態樣中，本發明提供一種製造二胺之方法，其包含：(i)培養具有腐胺二胺之微生物，其中經引入或增強具有SEQ ID NO：6的胺基酸序列或具有42%或更高的與之序列同源性之胺基酸序列的蛋白之活性，以便獲得細胞培養物；及(ii)自經培養之微生物或細胞培養物回收二胺。
 In another aspect, the invention provides a method of making a diamine comprising: (i) cultivating a microorganism having putrescine diamine, wherein the amino acid sequence having SEQ ID NO: 6 is introduced or enhanced or has 42% or more of the activity of the protein of the amino acid sequence of sequence homology to obtain a cell culture; and (ii) recovering the diamine from the cultured microorganism or cell culture.
 
 
 
   二胺、具有SEQ ID NO：6的胺基酸序列之蛋白或具有42%或更高的與之序列同源性的胺基酸序列之蛋白、蛋白活性之引入、蛋白活性之增強、二胺及具有二胺生產力之微生物與上文所述相同。
 a diamine, a protein having the amino acid sequence of SEQ ID NO: 6 or a protein having an amino acid sequence of 42% or higher sequence homology, introduction of protein activity, enhancement of protein activity, diamine And microorganisms having diamine productivity are the same as described above.
 
 
 
   在該方法中，培養微生物之步驟可(但未特定限於)較佳地藉由此項技術中已知之分批培養、持續培養及分批饋料培養執行。就此而言，培養條件並未受特定限制，但最佳pH(例如pH 5至pH 9，較佳地pH 6至pH 8，且最佳地pH 6.8)可藉由使用鹼性化學製品(例如氫氧化鈉、氫氧化鉀或氨水)或酸性化學製品(例如磷酸或硫酸)來維持。另外，需氧條件可藉由向細胞培養物中添加氧氣或含氧氣體混合物來維持。培養溫度可維持於20至45℃下，且較佳地25至40℃下，且培養可執行約10至160小時。
 In this method, the step of culturing the microorganism can be, but is not particularly limited to, preferably performed by batch culture, continuous culture, and batch feed culture as known in the art. In this regard, the culture conditions are not particularly limited, but an optimum pH (e.g., pH 5 to pH 9, preferably pH 6 to pH 8, and optimal pH 6.8) can be achieved by using an alkaline chemical (e.g., Sustained by sodium hydroxide, potassium hydroxide or aqueous ammonia or acidic chemicals such as phosphoric acid or sulfuric acid. Additionally, aerobic conditions can be maintained by the addition of oxygen or an oxygen-containing gas mixture to the cell culture. The culture temperature can be maintained at 20 to 45 ° C, and preferably at 25 to 40 ° C, and the culture can be performed for about 10 to 160 hours.
 
 
 
   此外，欲用於培養之培養基可包括個別地或組合作為碳源之糖及碳水化合物(例如，葡萄糖、蔗糖、乳糖、果糖、麥芽糖、糖蜜、澱粉及纖維素)、油及脂肪(例如，大豆油、向日葵籽油、花生油及椰子油)、脂肪酸(例如，棕櫚酸、
硬脂酸及亞油酸)、醇(例如，甘油及乙醇)及有機酸(例如，乙酸)；個別地或組合作為氮源之含氮有機化合物(例如，蛋白腖、酵母提取物、肉汁、麥芽提取物、玉米溶液、大豆粉及脲)或無機化合物(例如，硫酸銨、氯化銨、磷酸銨、碳酸銨及硝酸銨)；個別地或組合作為磷源之磷酸二氫鉀、磷酸二鉀或與其對應之含鈉鹽；其他必需生長刺激物，包括金屬鹽(例如，硫酸鎂或硫酸鐵)、胺基酸及維生素。在本發明中，培養基可用作培養液體之同義語。
 Further, the medium to be used for the culture may include sugars and carbohydrates (for example, glucose, sucrose, lactose, fructose, maltose, molasses, starch, and cellulose), oil, and fat, individually or in combination as a carbon source (for example, large Soybean oil, sunflower seed oil, peanut oil and coconut oil), fatty acids (eg palmitic acid,
Stearic acid and linoleic acid), alcohols (for example, glycerol and ethanol), and organic acids (for example, acetic acid); nitrogen-containing organic compounds (for example, peptone, yeast extract, gravy, wheat), individually or in combination as a nitrogen source Bud extract, corn solution, soy flour and urea) or inorganic compounds (for example, ammonium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate and ammonium nitrate); potassium dihydrogen phosphate or phosphoric acid, either alone or in combination as a phosphorus source Potassium or its corresponding sodium salt; other essential growth stimuli, including metal salts (eg, magnesium sulfate or ferric sulfate), amino acids, and vitamins. In the present invention, the medium can be used as a synonym for culturing a liquid.
 
 
 
   如本文所用，術語「細胞培養物」為藉由培養微生物獲得之材料，且包括培養基、所培養之微生物及自所培養之微生物釋放的物質。例如，可包括細胞培養物所需之營養供應源，諸如礦物質、胺基酸、維生素、核酸及/或除碳源及氮源以外一般含於培養基(或培養液體)中之其他組分。此外，可包括所需物質或由細胞製造/分泌之酶。
 As used herein, the term "cell culture" is a material obtained by culturing a microorganism, and includes a medium, a microorganism to be cultured, and a substance released from the microorganism to be cultured. For example, a nutrient supply source required for the cell culture, such as minerals, amino acids, vitamins, nucleic acids, and/or other components generally contained in the culture medium (or culture liquid) other than the carbon source and the nitrogen source, may be included. In addition, the desired substance or an enzyme produced/secreted by the cell may be included.
 
 
 
   由於由培養物製造之二胺可分泌至培養基中或保留於細胞中，細胞培養物可包括藉由培養微生物所製造之二胺。
 Since the diamine produced from the culture can be secreted into the medium or retained in the cells, the cell culture can include a diamine produced by culturing the microorganism.
 
 
 
   回收在本發明之培養步驟中製造之腐胺的方法可例如使用此項技術中已知之合適方法根據培養方法，例如分批培養、持續培養或分批饋料培養來進行，藉此自培養液體收集所需胺基酸。
 The method of recovering the putrescine produced in the culturing step of the present invention can be carried out, for example, by a culture method such as batch culture, continuous culture or batch feed culture using a suitable method known in the art, thereby self-cultivating the liquid. The desired amino acid was collected.
 
 
 
 
 
   在本發明中，已證明溶血隱秘桿菌源性ARCH_0271蛋白為具有二胺輸出活性之蛋白，且腐胺輸出活性可藉由
將此蛋白活性引入至具有腐胺合成路徑但具有低腐胺輸出活性之棒狀桿菌屬微生物中來增強。亦已證明，腐胺及屍胺之產生可同時藉由將此蛋白活性引入至具有腐胺及屍胺之合成路徑的大腸桿菌中來增加。因此，二胺可有效地藉由將溶血隱秘桿菌源性ARCH_0271蛋白應用於具有二胺生產力之微生物來製造。
 In the present invention, it has been confirmed that the cryptobacter cholerae-derived ARCH_0271 protein is a protein having diamine export activity, and the putrescine output activity can be obtained by
This protein activity is enhanced by introduction into a microorganism of the genus Corynebacterium having a putrescine synthesis pathway but having a low putrescine output activity. It has also been demonstrated that the production of putrescine and cadaverine can be simultaneously increased by introducing this protein activity into E. coli having a synthetic pathway of putrescine and cadaverine. Therefore, the diamine can be efficiently produced by applying the hemolytic cryptobacteria-derived ARCH_0271 protein to a microorganism having diamine productivity.
 
 
 
 
 
 
   下文中，本發明將參考實例更詳細地加以描述。然而，此等實例僅用於說明性目的，且本發明不意欲受此等實例限制。
 Hereinafter, the present invention will be described in more detail with reference to examples. However, such examples are for illustrative purposes only and the invention is not intended to be limited by such examples.
 
 
 
 
   參考實例1.製備具有腐胺生產力之棒狀桿菌屬微生物 Reference Example 1. Preparation of a Corynebacterium microorganism having putrescine productivity 
 
 
 
   已證實當作為具有腐胺生產力之棒狀桿菌屬微生物的基於麩胺酸棒狀桿菌ATCC13032之產腐胺菌株KCCM11240P(韓國發明專利公開案第2013-0082478號)及基於麩胺酸棒狀桿菌ATCC13869之產腐胺菌株DAB12-a △NCgl1469(ArgF刪除、NCgl1221刪除、大腸桿菌speC引入、Arg操縱子啟動子取代、NCgl1469刪除；指定為DAB 12-b，韓國發明專利公開案第2013-0082478號)中刪除NCgl2522(屬於主要協助轉運蛋白超家族(MFS)之透性酶)時，腐胺產生減少。
 It has been confirmed that the putrescine-producing strain KCCM11240P (Korean Invention Patent Publication No. 2013-0082478) based on Corynebacterium glutamicum ATCC13032 which is a microorganism of the genus Corynebacterium having putrescine productivity, and Corynebacterium glutamicum ATCC13869 Putrescine-producing strain DAB12-a △NCgl1469 (ArgF deletion, NCgl1221 deletion, E. coli speC introduction, Arg operon promoter substitution, NCgl1469 deletion; designated as DAB 12-b, Korean Invention Patent Publication No. 2013-0082478) When NCgl2522, which is a permease that mainly assists the transporter superfamily (MFS), is deleted, the production of putrescine is reduced.
 
 
 
   亦已證實，腐胺在藉由將NCgl2522基因額外引入至
KCCM11240P或DAB12-b中之轉位子中或藉由用CJ7啟動子取代染色體上之NCgl2522啟動子以增強NCgl2522活性而製備之麩胺酸棒狀桿菌菌株中以高產率製造。此外，腐胺之細胞內的量在其中NCgl2522表現增強之菌株中量測，且結果，與對照組之量相比，觀察到較少量之腐胺。由此指示NCgl2522具有輸出腐胺之能力。
 It has also been demonstrated that putrescine is additionally introduced by the NCgl2522 gene.
The transglutinin of KCCM11240P or DAB12-b or a strain of Corynebacterium glutamicum prepared by substituting the NCgl2522 promoter on the chromosome with the CJ7 promoter to enhance NCgl2522 activity is produced in high yield. Further, the intracellular amount of putrescine was measured in a strain in which NCgl2522 was enhanced, and as a result, a smaller amount of putrescine was observed as compared with the amount of the control group. This indicates that NCgl2522 has the ability to output putrescine.
 
 
 
   詳言之，基於編碼麩胺酸棒狀桿菌ATCC13032之NCgl2522的基因之核苷酸序列，一對用於獲得NCgl2522之N-端區域的同源重組片段之引子SEQ ID NO：1及SEQ ID NO：2及一對用於獲得NCgl2522之C-端區域的同源重組片段之引子SEQ ID NO：3及SEQ ID NO：4如下表1中使用。
 In detail, based on the nucleotide sequence of the gene encoding NCgl2522 of Corynebacterium glutamicum ATCC13032, a pair of primers for obtaining a homologous recombination fragment of the N-terminal region of NCgl2522, SEQ ID NO: 1 and SEQ ID NO : 2 and a pair of primers for obtaining a homologous recombination fragment of the C-terminal region of NCgl2522 SEQ ID NO: 3 and SEQ ID NO: 4 are used in Table 1 below.
 
 
 
 
 
 
 
 
 
 
 
 
 
   使用作為模板之麩胺酸棒狀桿菌ATCC13032之基因組DNA及兩對引子執行PCR以便分別擴增N-端及C-端區域之PCR片段。此等PCR片段進行電泳以獲得所需片段。此時，進行PCR反應：在95℃下變性30秒，在55℃下退火30秒，且在72℃下延伸30秒，持續30個循環。因此獲得之N-端區域的片段用限制酶BamHI及SalI處理，且
因此獲得之C-端區域的片段用限制酶SalI及XbaI處理。因此處理之片段選殖至用限制酶BamHI及XbaI處理之pDZ載體中，以便構築質體pDZ-1’NCgl2522(K/O)。
 PCR was carried out using genomic DNA of Corynebacterium glutamicum ATCC13032 as a template and two pairs of primers to amplify the PCR fragments of the N-terminal and C-terminal regions, respectively. These PCR fragments were subjected to electrophoresis to obtain the desired fragment. At this time, a PCR reaction was carried out: denaturation at 95 ° C for 30 seconds, annealing at 55 ° C for 30 seconds, and elongation at 72 ° C for 30 seconds for 30 cycles. The fragment of the N-terminal region thus obtained is treated with the restriction enzymes BamHI and SalI, and
The fragment of the C-terminal region thus obtained was treated with the restriction enzymes SalI and XbaI. The treated fragment was thus cloned into the pDZ vector treated with the restriction enzymes BamHI and XbaI to construct the plastid pDZ-1'NCgl2522 (K/O).
 
 
 
   質體pDZ-1’NCgl2522(K/O)藉由電穿孔引入至麩胺酸棒狀桿菌KCCM11240P中，以便獲得轉型體。接著，該轉型體塗於含有用於菌落形成之卡那黴素(25μg/ml)及X-gal(5-溴-4-氯-3-吲哚啉-D-半乳糖苷)的BHIS培養板(37g/l腦心浸液、91g/l山梨糖醇及2%瓊脂)上且培養。自因此形成之菌落選擇藍色菌落作為引入質體pDZ-1’NCgl2522(K/O)之菌株。
 The plastid pDZ-1'NCgl2522 (K/O) was introduced into Corynebacterium glutamicum KCCM11240P by electroporation to obtain a transformant. Next, the transformation was applied to BHIS culture containing kanamycin (25 μg/ml) for colony formation and X-gal (5-bromo-4-chloro-3-porphyrin-D-galactoside). Plates (37 g/l brain heart infusion, 91 g/l sorbitol and 2% agar) were incubated. Blue colonies were selected as colonies introduced into the plastid pDZ-1'NCgl2522 (K/O) from the colonies thus formed.
 
 
 
   所選擇之菌株在震盪下在CM培養基(10g/l葡萄糖、10g/l聚蛋白腖、5g/l酵母提取物、5g/l牛肉提取物、2.5g/l NaCl及2g/l脲，pH 6.8)中在30℃下培養8小時。隨後，各細胞培養物連續地自10 -4 稀釋至10 -10 。接著，經稀釋之樣品塗於用於菌落形成之含X-gal固體培養基上且培養。自因此形成之菌落選擇以相對較低頻率出現的白色菌落以最終獲得其中編碼NCgl2522之基因刪除且腐胺生產力減弱之麩胺酸棒狀桿菌菌株。其中腐胺輸出活性減弱之麩胺酸棒狀桿菌菌株指定為KCCM11240P △NCgl2522。
 The selected strain was shaken in CM medium (10 g/l glucose, 10 g/l polypeptone, 5 g/l yeast extract, 5 g/l beef extract, 2.5 g/l NaCl and 2 g/l urea, pH 6.8) The medium was cultured at 30 ° C for 8 hours. Subsequently, each cell culture was continuously diluted from 10  -4  to 10  -10  . Next, the diluted sample was applied to an X-gal solid medium for colony formation and cultured. From the thus formed colonies, white colonies appearing at a relatively low frequency were selected to finally obtain a strain of Corynebacterium glutamicum in which the gene encoding NCgl2522 was deleted and the putrescine productivity was weakened. The Corynebacterium glutamicum strain in which the putrescine output activity was weakened was designated as KCCM11240P ΔNCgl2522. 
 
 
   以相同方式，使用作為模板之麩胺酸棒狀桿菌ATCC13869之基因組DNA及表1中給出之兩對引子執行PCR以便藉由上文所述之方法構築質體pDZ-2’NCgl2522(K/O)。構築麩胺酸棒狀桿菌菌株，其中根據上文所述之方法使用該載體使編碼DAB12-b菌株之
NCgl2522的基因刪除以減弱腐胺生產力。此具有減弱之腐胺輸出活性的麩胺酸棒狀桿菌菌株指定為DAB12-b △NCgl2522。
 In the same manner, PCR was carried out using the genomic DNA of Corynebacterium glutamicum ATCC13869 as a template and the two pairs of primers given in Table 1 to construct the plastid pDZ-2'NCgl2522 by the method described above (K/ O). Constructing a strain of Corynebacterium glutamicum, wherein the vector is used to encode a DAB12-b strain according to the method described above
Gene deletion of NCgl2522 to attenuate putrescine productivity. This Corynebacterium glutamicum strain having attenuated putrescine output activity was designated as DAB12-b ΔNCgl2522.
 
 
 
 
   實例1.選擇溶血隱秘桿菌ARCH_0271 Example 1. Selection of hemolytic bacterium ARCH_0271 
 
 
 
   如參考實例1中所證實，發現NCgl2522膜蛋白用於輸出腐胺。因此，基於NCgl2522之胺基酸序列，本發明的發明人使用國家生物技術資訊中心(National Center for Biotechnology Information,NCBI,www.ncbi.nlm.nih.gov)之BlastP程式檢查除棒狀桿菌屬基因外與之具有同源性之基因，且結果，其獲得溶血隱秘桿菌DSM 20595之ARCH_0271的核苷酸序列(SEQ ID NO：5)及胺基酸序列(SEQ ID NO：6)，該ARCH_0271與之具有56%同源性。在非棒狀桿菌屬之其他屬中發現的與NCgl2522之胺基酸序列具有同源性之膜蛋白中，ARCH_0271之胺基酸序列在系統發育方面與NCgl2522之胺基酸序列最接近。
 As confirmed in Reference Example 1, NCgl2522 membrane protein was found to be used to export putrescine. Therefore, based on the amino acid sequence of NCgl2522, the inventors of the present invention examined the Corynebacterium gene using the BlastP program of the National Center for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov). a gene having homology to it, and as a result, it obtains the nucleotide sequence (SEQ ID NO: 5) and the amino acid sequence (SEQ ID NO: 6) of ARCH_0271 of C. hemolyticus DSM 20595, which is related to ARCH_0271 and It has 56% homology. Among the membrane proteins homologous to the amino acid sequence of NCgl2522 found in other genus of the genus Corynebacterium, the amino acid sequence of ARCH_0271 is phylogenetically closest to the amino acid sequence of NCgl2522.
 
 
 
   以相同方式，獲得源自糞產鹼菌糞亞種NCIB 8687之QWA_00075的核苷酸序列(SEQ ID NO：22)及胺基酸序列(SEQ ID NO：23)，QWA_00075顯示與NCgl2522之胺基酸序列41%同源性；及源自嗜麥芽寡養單胞菌D457之SMD_2351的核苷酸序列(SEQ ID NO：25)及胺基酸序列(SEQ ID NO：26)，SMD_2351顯示與NCgl2522之胺基酸序列52%同源性。QWA_00075之胺基酸序列及SMD_2351之胺基酸序列分別顯示與ARCH_0271之胺基酸序列42%
及47%同源性，如下表2中所顯示。
 In the same manner, the nucleotide sequence (SEQ ID NO: 22) and the amino acid sequence (SEQ ID NO: 23) derived from QWA_00075 of the genus Alcaligenes subsp. NCIB 8687 were obtained, and QWA_00075 showed an amine group with NCgl2522. 41% homology of the acid sequence; and the nucleotide sequence (SEQ ID NO: 25) and amino acid sequence (SEQ ID NO: 26) derived from SMD-2351 of S. maltophilia D457, SMD_2351 showed The amino acid sequence of NCgl2522 is 52% homologous. The amino acid sequence of QWA_00075 and the amino acid sequence of SMD_2351 showed 42% of the amino acid sequence of ARCH_0271, respectively.
And 47% homology, as shown in Table 2 below.
 
 
 
 
 
 
 
 
 
 
 
 
 
   同時，具有顯示與NCgl2522之同源性的基因之微生物及其同源性在下表3中給出。
 Meanwhile, microorganisms having a gene showing homology with NCgl2522 and homology thereof are given in Table 3 below.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   實例2.藉由將具有腐胺輸出活性之蛋白引入至源自棒狀桿菌屬之產腐胺菌株中使腐胺發酵 Example 2. Fermentation of putrescine by introducing a protein having putrescine export activity into a putrescine-producing strain derived from Corynebacterium 
 
 
 
 
   <2-1>將ARCH_0271、QWA_00075或SMD_2351引入至基於ATCC13032之產腐胺菌株之染色體中的轉位子基因中 <2-1> Introducing ARCH_0271, QWA_00075 or SMD_2351 into the transposon gene in the chromosome of the putrescine-producing strain based on ATCC13032 
 
 
 
   為了檢查ARCH_0271、QWA_00075或SMD_2351基因之染色體插入是否影響在參考實例1中製備之具有降低的腐胺輸出活性之KCCM11240P △NCgl2522的腐胺輸出，藉由以下方法將ARCH_0271、QWA_00075或SMD_2351引入至轉位子基因中。
 In order to examine whether the chromosomal insertion of the ARCH_0271, QWA_00075 or SMD_2351 gene affects the putrescine output of KCCM11240P ΔNCgl2522 having reduced putrescine output activity prepared in Reference Example 1, ARCH_0271, QWA_00075 or SMD_2351 was introduced into the transposon by the following method In the gene.
 
 
 
   作為允許使用棒狀桿菌屬微生物之轉位子基因將基因插入至染色體中之用於轉型之載體，使用pDZTn(WO 2009/125992)，且CJ7(WO 2006/65095)用作啟動子。
 As a vector for transformation which allows insertion of a gene into a chromosome using a transposon gene of a microorganism of the genus Corynebacterium, pDZTn (WO 2009/125992) was used, and CJ7 (WO 2006/65095) was used as a promoter.
 
 
 
   基於溶血隱秘桿菌DSM 20595之核苷酸序列，藉由針對麩胺酸棒狀桿菌之密碼子用法最佳化核苷酸序列(SEQ ID NO：7)來合成ARCH_0271基因。以相同方式，亦藉由
針對麩胺酸棒狀桿菌之密碼子用法最佳化核苷酸序列(SEQ ID NO：24及SEQ ID NO：27)來分別合成源自糞產鹼菌糞亞種NCIB 8687之QWA_00075及源自嗜麥芽寡養單胞菌D457之SMD_2351。所合成之基因作為選殖至pGEM B1中之基因獲得。
 Based on the nucleotide sequence of C. hemolyticus DSM 20595, the ARCH_0271 gene was synthesized by optimizing the nucleotide sequence (SEQ ID NO: 7) for codon usage of Corynebacterium glutamicum. In the same way, also by
The nucleotide sequence (SEQ ID NO: 24 and SEQ ID NO: 27) was optimized for codon usage of Corynebacterium glutamicum to synthesize QWA_00075 derived from the subsp. SMD_2351 of S. maltophilia D457. The synthesized gene was obtained as a gene selected for pGEM B1.
 
 
 
   因此獲得之質體分別指定為pGEM B1-ARCH_0271、pGEM B1-QWA_00075及pGEM B1-SMD_2351。
 The plastids thus obtained were designated as pGEM B1-ARCH_0271, pGEM B1-QWA_00075, and pGEM B1-SMD_2351, respectively.
 
 
 
   約1.51kb、1.53kb或1.53kb之基因片段分別使用作為模板之pGEM B1-ARCH_0271、pGEM B1-QWA_00075或pGEM B1-SMD_2351質體及一對引子SEQ ID NO：10及SEQ ID NO：11、SEQ ID NO：28及SEQ ID NO：29或SEQ ID NO：30及SEQ ID NO：31(參見表4)擴增。此時，進行PCR反應：在95℃下變性30秒，在55℃下退火30秒，且在72℃下延伸1分30秒，持續30個循環。接著，此等PCR產物在0.8%瓊脂糖凝膠上進行電泳以溶離且純化所需大小的各色帶。
 A gene fragment of about 1.51 kb, 1.53 kb, or 1.53 kb was used as a template for pGEM B1-ARCH_0271, pGEM B1-QWA_00075 or pGEM B1-SMD_2351 plastid and a pair of primers SEQ ID NO: 10 and SEQ ID NO: 11, SEQ, respectively. ID NO: 28 and SEQ ID NO: 29 or SEQ ID NO: 30 and SEQ ID NO: 31 (see Table 4) were amplified. At this time, a PCR reaction was carried out: denaturation at 95 ° C for 30 seconds, annealing at 55 ° C for 30 seconds, and extension at 72 ° C for 1 minute and 30 seconds for 30 cycles. Next, these PCR products were electrophoresed on a 0.8% agarose gel to dissolve and purify each ribbon of the desired size.
 
 
 
   此外，藉由使用作為模板之p117-Pcj7-gfp及一對引子SEQ ID NO：8及SEQ ID NO：9(參見表4)進行PCR來獲得CJ7啟動子區域：在95℃下變性30秒，在55℃下退火30秒，且在72℃下延伸30秒，持續30個循環。CJ7啟動子基因之片段在0.8%瓊脂糖凝膠上進行電泳以溶離且純化所需大小的色帶。
 Furthermore, the CJ7 promoter region was obtained by PCR using p117-Pcj7-gfp as a template and a pair of primers SEQ ID NO: 8 and SEQ ID NO: 9 (see Table 4): denaturation at 95 ° C for 30 seconds, Annealed at 55 ° C for 30 seconds and at 72 ° C for 30 seconds for 30 cycles. Fragments of the CJ7 promoter gene were electrophoresed on a 0.8% agarose gel to dissolve and purify the ribbon of the desired size.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   pDZTn載體用 Xho I消化，且執行以上所獲得之各PCR產物的融合選殖。In-Fusion◎HD選殖套組(Clontech)用於融合選殖。所得質體分別指定為pDZTn-P(cj7)-ARCH_0271、pDZTn-P(cj7)-QWA_00075及pDZTn-P(cj7)-SMD_2351。
 The pDZTn vector was digested with  Xho  I and the fusion selection of each of the PCR products obtained above was performed. In-Fusion ◎ HD selection kit (Clontech) was used for fusion selection. The obtained plasmids were designated as pDZTn-P(cj7)-ARCH_0271, pDZTn-P(cj7)-QWA_00075, and pDZTn-P(cj7)-SMD_2351, respectively. 
 
 
   三種質體pDZTn-P(cj7)-ARCH_0271、pDZTn-P(cj7)-QWA_00075及pDZTn-P(cj7)-SMD_2351中之每一者均藉由電穿孔引入至參考實例1中所述之具有降低的腐胺輸出活性之麩胺酸棒狀桿菌KCCM11240P △NCgl2522中以獲得轉型體。該等轉型體在震盪下在CM培養基(10g/l葡萄糖、10g/l聚蛋白腖、5g/l酵母提取物、5g/l牛肉提取物、2.5g/l NaCl及2g/l脲，pH 6.8)中培養(30℃下持續8小時)。隨後，各細胞培養物連續自10 -4 稀釋至10 -10 。接著，經稀釋之樣品塗於用於菌落形成之含X-gal固體培養基上且培養。
 Each of the three plastids pDZTn-P(cj7)-ARCH_0271, pDZTn-P(cj7)-QWA_00075, and pDZTn-P(cj7)-SMD_2351 was reduced by electroporation as described in Reference Example 1. The putrescine export activity of Corynebacterium glutamicum KCCM11240P △NCgl2522 to obtain the transformant. The transition bodies were shaken in CM medium (10 g/l glucose, 10 g/l polypeptone, 5 g/l yeast extract, 5 g/l beef extract, 2.5 g/l NaCl and 2 g/l urea, pH 6.8) Medium culture (for 8 hours at 30 ° C). Subsequently, each cell culture was continuously diluted from 10  -4  to 10  -10  . Next, the diluted sample was applied to an X-gal solid medium for colony formation and cultured. 
 
 
   自所形成之菌落選擇以相對較低頻率出現的白色菌落
以最終獲得其中藉由二次雜交引入編碼ARCH_0271、QWA_00075或SMD_2351之基因的菌株。最終選擇之菌株使用一對引子SEQ ID NO：8及SEQ ID NO：11、SEQ ID NO：8及SEQ ID NO：29或SEQ ID NO：8及SEQ ID NO：31進行PCR以確認引入編碼ARCH_0271、QWA_00075或SMD_2351之基因。此等麩胺酸棒狀桿菌突變型菌株分別指定為KCCM11240P △NCgl2522 Tn：P(cj7)-ARCH_0271、KCCM11240P △NCgl2522 Tn：P(cj7)-QWA_00075及KCCM11240P △NCgl2522 Tn：P(cj7)-SMD_2351。
 Selecting white colonies that appear at a relatively low frequency from the colonies formed
A strain in which a gene encoding ARCH_0271, QWA_00075 or SMD_2351 is introduced by secondary hybridization is finally obtained. The finally selected strain was subjected to PCR using a pair of primers SEQ ID NO: 8 and SEQ ID NO: 11, SEQ ID NO: 8 and SEQ ID NO: 29 or SEQ ID NO: 8 and SEQ ID NO: 31 to confirm the introduction of the encoding ARCH_0271 , QWA_00075 or SMD_2351 gene. These mutant strains of Corynebacterium glutamicum were designated as KCCM11240P △NCgl2522 Tn:P(cj7)-ARCH_0271, KCCM11240P △NCgl2522 Tn:P(cj7)-QWA_00075 and KCCM11240P △NCgl2522 Tn:P(cj7)-SMD_2351.
 
 
 
 
   <2-2>將ARCH_0271、QWA_00075或SMD_2351引入至基於ATCC13869之產腐胺菌株之染色體中的轉位子基因中 <2-2> Introducing ARCH_0271, QWA_00075 or SMD_2351 into the transposon gene in the chromosome of the putrescine-producing strain based on ATCC13869 
 
 
 
   為了檢查ARCH_0271基因之染色體插入是否影響參考實例1中製備之具有降低的腐胺輸出活性之DAB12-b △NCgl2522的腐胺輸出，將上文製備之pDZTn-P(cj7)-ARCH_0271、pDZTn-P(cj7)-QWA_00075或pDZTn-P(cj7)-SMD_2351引入至麩胺酸棒狀桿菌DAB12-b △NCgl2522中且以與實例<2-1>中相同的方式確認菌株之轉位子基因中引入ARCH_0271、QWA_00075或SMD_2351。
 In order to examine whether the chromosomal insertion of the ARCH_0271 gene affects the putrescine output of DAB12-b ΔNCgl2522 having reduced putrescine output activity prepared in Reference Example 1, the above prepared pDZTn-P(cj7)-ARCH_0271, pDZTn-P (cj7)-QWA_00075 or pDZTn-P(cj7)-SMD_2351 was introduced into Corynebacterium glutamicum DAB12-b ΔNCgl2522 and the introduction of ARCH_0271 into the transposon gene of the strain was confirmed in the same manner as in Example <2-1>. , QWA_00075 or SMD_2351.
 
 
 
   因此選擇之麩胺酸棒狀桿菌突變型菌株分別指定為DAB12-b △NCgl2522 Tn：P(cj7)-ARCH_0271、DAB12-b △NCgl2522 Tn：P(cj7)-QWA_00075及DAB12-b △NCgl2522 Tn：P(cj7)-SMD_2351。
 Therefore, the selected strains of Corynebacterium glutamicum were designated as DAB12-b △NCgl2522 Tn:P(cj7)-ARCH_0271, DAB12-b △NCgl2522 Tn:P(cj7)-QWA_00075 and DAB12-b △NCgl2522 Tn: P(cj7)-SMD_2351.
 
 
 
 
   <2-3>評估引入ARCH_0271、QWA_00075或SMD_2351之棒狀桿菌屬源性產腐胺菌株的腐胺生產力 <2-3>Evaluate the putrescine productivity of Corynebacterium-derived putrescine strains introduced with ARCH_0271, QWA_00075 or SMD_2351 
 
 
 
   為了確認ARCH_0271引入對產腐胺菌株之腐胺生產力的效果，比較在實例<2-1>及<2-2>中製備之麩胺酸棒狀桿菌突變型菌株的腐胺生產力。
 In order to confirm the effect of introduction of ARCH_0271 on the putrescine productivity of the putrescine-producing strain, the putrescine productivity of the mutant strain of Corynebacterium glutamicum prepared in Examples <2-1> and <2-2> was compared.
 
 
 
   詳言之，將10種類型之麩胺酸棒狀桿菌突變體(KCCM11240P；KCCM11240P △NCgl2522；KCCM11240P △NCgl2522 Tn：P(cj7)-ARCH_0271；KCCM11240P △NCgl2522 Tn：P(cj7)-QWA_00075；KCCM11240P △NCgl2522 Tn：P(cj7)-SMD_2351；DAB12-b；DAB12-b △NCgl2522；DAB12-b △NCgl2522 Tn：P(cj7)-ARCH_0271；DAB12-b △NCgl2522 Tn：P(cj7)-QWA_00075及DAB12-b △NCgl2522 Tn：P(cj7)-SMD_2351)分別塗於含1mM精胺酸之CM板培養基(1%葡萄糖、1%聚蛋白腖、0.5%酵母提取物、0.5%牛肉提取物、0.25% NaCl、0.2%脲、100μl 50% NaOH及2%瓊脂，pH 6.8，以1L計)上，且在30℃下培養24小時。將1鉑環的因此培養之各菌株接種於25ml滴定培養基(8%葡萄糖、0.25%大豆蛋白、0.50%玉米浸漬固體、4%(NH 4 ) 2 SO 4 、0.1% KH 2 PO 4 、0.05% MgSO 4 ．7H 2 O、0.15%脲、100μg生物素、3mg硫胺鹽酸鹽、3mg鈣-泛酸、3mg菸鹼醯胺及5% CaCO 3 ，pH 7.0，以1L計)中，且接著在震盪下在30℃及200rpm下培養98小時。將1mM精胺酸添加至用於培養該等菌株之所有培養基中。量測各細胞培養物中之腐胺濃度，且結果顯示於下表5中。
 In detail, 10 types of Corynebacterium glutamicum mutants (KCCM11240P; KCCM11240P △NCgl2522; KCCM11240P △NCgl2522 Tn:P(cj7)-ARCH_0271; KCCM11240P △NCgl2522 Tn:P(cj7)-QWA_00075; KCCM11240P △ NCgl2522 Tn:P(cj7)-SMD_2351;DAB12-b;DAB12-b △NCgl2522;DAB12-b △NCgl2522 Tn:P(cj7)-ARCH_0271;DAB12-b △NCgl2522 Tn:P(cj7)-QWA_00075 and DAB12- b △NCgl2522 Tn:P(cj7)-SMD_2351) were applied to CM plate medium containing 1 mM arginine (1% glucose, 1% polypeptone, 0.5% yeast extract, 0.5% beef extract, 0.25% NaCl, 0.2% urea, 100 μl 50% NaOH and 2% agar, pH 6.8, on a 1 L basis, and cultured at 30 ° C for 24 hours. Each of the thus cultured strains of 1 platinum loop was inoculated into 25 ml of titration medium (8% glucose, 0.25% soy protein, 0.50% corn impregnated solid, 4% (NH  4  )  2  SO  4  , 0.1% KH  2  PO  4  , 0.05% MgSO  4  .7H  2  O, 0.15% urea, 100 μg biotin, 3 mg thiamine hydrochloride, 3 mg calcium-pantothenic acid, 3 mg nicotine guanamine and 5% CaCO  3  , pH 7.0, in 1 L), and then Incubate for 98 hours at 30 ° C and 200 rpm under shaking. 1 mM arginine was added to all the medium used to culture the strains. The concentration of putrescine in each cell culture was measured and the results are shown in Table 5 below. 
 
 
 
 
 
 
 
 
 
 
 
 
   如表5中所顯示，發現腐胺產生在兩種類型之引入ARCH_0271之麩胺酸棒狀桿菌突變型菌株中均增加。此外，發現與親本菌株KCCM 11240P △NCgl2522或DAB12-b △NCgl2522相比，腐胺產生在引入QWA_00075或SMD_2351之菌株中增加。由此指示QWA_00075或SMD_2351具有腐胺輸出活性。
 As shown in Table 5, it was found that putrescine production increased in both types of mutant strains of Corynebacterium glutamicum introduced into ARCH_0271. Furthermore, it was found that putrescine production was increased in the strain introduced with QWA_00075 or SMD_2351 as compared with the parental strain KCCM 11240P ΔNCgl2522 or DAB12-b ΔNCgl2522. This indicates that QWA_00075 or SMD_2351 has putrescine output activity.
 
 
 
 
   實例3.藉由棒狀桿菌屬源性產離胺酸菌株中之ARCH_0271引入及離胺酸去羧酶表現使屍胺發酵 Example 3. Fermentation of cadaverine by ARCH_0271 introduction and lysine decarboxylase expression in a strain of Corynebacterium-derived lysine 
 
 
 
 
   <3-1>在產L-離胺酸之麩胺酸棒狀桿菌KCCM11016P之染色體中的轉位子基因中引入ARCH_0271 <3-1> Introduction of ARCH_0271 into the transposon gene in the chromosome of the lysogenic bacterium of the glutamate KCCM11016P 
 
 
 
   為了確認ARCH_0271蛋白之屍胺輸出活性，將ARCH_0271基因引入至產離胺酸菌株KCCM11016P之染
色體中(此微生物在1995年12月18日以寄存號KFCC10881寄存於韓國微生物培養中心，且接著根據布達佩斯條約以寄存號KCCM11016P寄存於國際寄存管理局，韓國發明專利第10-0159812號)。將上文製備之pDZTn-P(cj7)-ARCH_0271引入至麩胺酸棒狀桿菌KCCM11016P中且以與實例<2-1>中相同之方式確認菌株之轉位子中引入ARCH_0271。
 In order to confirm the cadaverine export activity of ARCH_0271 protein, the ARCH_0271 gene was introduced into the lysine-producing strain KCCM11016P.
In the color body (this microorganism was deposited at the Korean Microbiology Culture Center on December 18, 1995 under the registration number KFCC10881, and then deposited under the Budapest Treaty with the registration number KCCM11016P in the International Depository Authority, Korean Invention Patent No. 10-0159812). The pDZTn-P(cj7)-ARCH_0271 prepared above was introduced into Corynebacterium glutamicum KCCM11016P and ARCH_0271 was introduced into the transposon of the strain in the same manner as in Example <2-1>.
 
 
 
   因此選擇之麩胺酸棒狀桿菌突變型菌株指定為KCCM11016P Tn：P(cj7)-ARCH_0271。
 The selected strain of Corynebacterium glutamicum was therefore designated as KCCM11016P Tn:P(cj7)-ARCH_0271.
 
 
 
 
   <3-2>將大腸桿菌源性離胺酸去羧酶基因引入至引入ARCH_0271之產L-離胺酸菌株中 <3-2> Introducing the Escherichia coli-derived lysate decarboxylase gene into an L-lysine-producing strain introduced into ARCH_0271 
 
 
 
   在實例<3-1>中製備之引入ARCH_0271之產L-離胺酸菌株KCCM11016P Tn：P(cj7)-ARCH_0271中引入用於屍胺產生之呈質體形式之大腸桿菌源性離胺酸去羧酶基因。自NCBI數據庫獲得來自大腸桿菌之離胺酸去羧酶ldcC之核苷酸序列(SEQ ID NO：32)及胺基酸序列(SEQ ID NO：33)。
 Escherichia coli-derived lysine in plastid form for cadaverine production was introduced in the L-lysine-producing strain KCCM11016P Tn:P(cj7)-ARCH_0271 introduced into ARCH_0271 prepared in Example <3-1> Carboxase gene. The nucleotide sequence (SEQ ID NO: 32) and the amino acid sequence (SEQ ID NO: 33) of the lysine decarboxylase ldcC from E. coli were obtained from the NCBI database.
 
 
 
   藉由使用作為模板之大腸桿菌W3110菌株的染色體及一對引子SEQ ID NO：36及SEQ ID NO：37(參見表6)進行PCR來獲得約2.1kb之ldcC基因片段：在95℃下變性30秒，在52℃下退火30秒，且在72℃下延伸2分鐘，持續30個循環。此產物用HindIII及XbaI處理，且接著在0.8%瓊脂糖凝膠中進行電泳以溶離且純化所需大小的色帶。
 Approximately 2.1 kb of the ldcC gene fragment was obtained by PCR using the chromosome of the Escherichia coli W3110 strain as a template and a pair of primers SEQ ID NO: 36 and SEQ ID NO: 37 (see Table 6): denaturation at 95 ° C 30 Seconds, annealed at 52 ° C for 30 seconds and extended at 72 ° C for 2 minutes for 30 cycles. This product was treated with HindIII and XbaI and then electrophoresed on a 0.8% agarose gel to dissolve and purify the ribbon of the desired size.
 
 
 
   此外，藉由使用作為模板之p117-Pcj7-gfp及一對引子
SEQ ID NO：34及SEQ ID NO：35(參見表6)進行PCR來獲得CJ7啟動子區域：在95℃下變性30秒，在55℃下退火30秒，且在72℃下延伸30秒，持續30個循環。CJ7啟動子基因之基因片段用KpnI及HindII處理，且接著在0.8%瓊脂糖凝膠上進行電泳以溶離且純化所需大小的色帶。
 In addition, by using p117-Pcj7-gfp as a template and a pair of primers
SEQ ID NO: 34 and SEQ ID NO: 35 (see Table 6) were subjected to PCR to obtain the CJ7 promoter region: denaturation at 95 ° C for 30 seconds, annealing at 55 ° C for 30 seconds, and extension at 72 ° C for 30 seconds, Lasts 30 cycles. The gene fragment of the CJ7 promoter gene was treated with KpnI and HindII, and then electrophoresed on a 0.8% agarose gel to dissolve and purify the ribbon of the desired size.
 
 
 
 
 
 
 
 
 
 
 
 
 
   使用T4 DNA連接酶(NEB)選殖藉由在0.8%瓊脂糖凝膠中對KpnI及XbaI處理之pECCG117(Biotechnology letters第13卷，第10期，第721-726頁(1991))載體執行電泳且接著溶離且純化所需大小的色帶所獲得之基因片段、用KpnI及HindIII處理之CJ7啟動子基因片段及用HindIII及XbaI處理之離胺酸去羧酶ldcC基因片段。藉由以上實驗獲得之編碼大腸桿菌ldcC之質體指定為pECCG117-Pcj7-ldcC。
 Electrophoresis was carried out by using T4 DNA ligase (NEB) by a vector of pECCG117 (Biotechnology letters, Vol. 13, No. 10, pp. 721-726 (1991)) treated with KpnI and XbaI in a 0.8% agarose gel. And then the gene fragment obtained by dissolving and purifying the ribbon of the desired size, the CJ7 promoter gene fragment treated with KpnI and HindIII, and the lysine decarboxylase ldcC gene fragment treated with HindIII and XbaI. The plastid encoding E. coli ldcC obtained by the above experiment was designated as pECCG117-Pcj7-ldcC.
 
 
 
   所製備之pECCG117-Pcj7-ldcC載體或pECCG117載體分別藉由電穿孔引入至KCCM11016P及KCCM11016P Tn：P(cj7)-ARCH_0271中。轉型體塗於含有用於選擇之25μg/ml卡那黴素的BHIS培養板上。所選擇之菌株分別指定
為KCCM11016P pECCG117、KCCM11016P pECCG117-Pcj7-ldcC、KCCM11016P Tn：P(cj7)-ARCH_0271 pECCG117及KCCM11016P Tn：P(cj7)-ARCH_0271 pECCG117-Pcj7-ldcC。
 The prepared pECCG117-Pcj7-ldcC vector or pECCG117 vector was introduced into KCCM11016P and KCCM11016P Tn:P(cj7)-ARCH_0271 by electroporation, respectively. The transformant was applied to a BHIS culture plate containing 25 μg/ml kanamycin for selection. Selected strains are designated separately
KCCM11016P pECCG117, KCCM11016P pECCG117-Pcj7-ldcC, KCCM11016P Tn:P(cj7)-ARCH_0271 pECCG117 and KCCM11016P Tn:P(cj7)-ARCH_0271 pECCG117-Pcj7-ldcC.
 
 
 
 
   <3-3>評估具有ARCH_0271之染色體插入及作為質體之離胺酸去羧酶基因的棒狀桿菌屬源性產離胺酸菌株之屍胺生產力 <3-3>Evaluating the cadaveric productivity of a bacterium belonging to the genus Corynebacterium-derived lysine producing a chromosomal insertion of ARCH_0271 and a lysine decarboxylase gene as a plastid 
 
 
 
   為了檢查將ARCH_0271引入至產屍胺菌株中是否影響屍胺產生，在實例<3-2>中製備之麩胺酸棒狀桿菌突變型菌株之間比較屍胺生產力。
 To examine whether the introduction of ARCH_0271 into the cadaverine-producing strain affects cadaverine production, the cadaveric productivity was compared between the mutant strains of Corynebacterium glutamicum prepared in Example <3-2>.
 
 
 
   詳言之，藉由以下方法培養4種類型之麩胺酸棒狀桿菌突變型菌株(KCCM11016P pECCG117；KCCM11016P pECCG117-Pcj7-ldcC；KCCM11016P Tn：P(cj7)-ARCH_0271 pECCG117；及KCCM11016P Tn：P(cj7)-ARCH_0271 pECCG117-Pcj7-ldcC)，且在其間比較屍胺生產力。
 In detail, four types of mutant strains of Corynebacterium glutamicum (KCCM11016P pECCG117; KCCM11016P pECCG117-Pcj7-ldcC; KCCM11016P Tn:P(cj7)-ARCH_0271 pECCG117; and KCCM11016P Tn:P were cultured by the following method. Cj7)-ARCH_0271 pECCG117-Pcj7-ldcC), and compare cadaverine productivity in between.
 
 
 
   個別突變型菌株塗於CM板培養基(1%葡萄糖、1%聚蛋白腖、0.5%酵母提取物、0.5%牛肉提取物、0.25% NaCl、0.2%脲、100μl 50% NaOH及2%瓊脂，pH 6.8，以1L計)上，且在30℃下培養24小時。所培養之菌株各自接種於含有25ml種子培養基(2%葡萄糖、1%蛋白腖、0.5%酵母提取物、0.15%脲、0.4% KH 2 PO 4 、0.8% K 2 HPO 4 、0.05% MgSO 4  7H 2 O、100μg生物素、1000μg硫胺HCl、2000μg鈣-泛酸及2000μg菸鹼醯胺，pH 7.0，以1L計)之250ml
三角燒瓶中，且在震盪下在30℃及200rpm下培養20小時。
 Individual mutant strains were applied to CM plate medium (1% glucose, 1% polypeptone, 0.5% yeast extract, 0.5% beef extract, 0.25% NaCl, 0.2% urea, 100 μl 50% NaOH, and 2% agar, pH 6.8 , on a 1 L basis, and incubated at 30 ° C for 24 hours. The cultured strains were each inoculated with 25 ml of seed medium (2% glucose, 1% peptone, 0.5% yeast extract, 0.15% urea, 0.4% KH  2  PO  4  , 0.8% K  2  HPO  4  , 0.05% MgSO  4  7H  2  O, 100 μg of biotin, 1000 μg of thiamine HCl, 2000 μg of calcium-pantothenic acid and 2000 μg of nicotinic acid amide, pH 7.0, in 1 L) in a 250 ml Erlenmeyer flask, and incubated at 30 ° C and 200 rpm for 20 hours under shaking. 
 
 
   接著，將1ml種子培養物接種於含有24ml製造培養基(4%葡萄糖、2%(NH 4 ) 2 SO 4 、2.5%大豆蛋白、5%玉米浸漬固體、0.3%脲、0.1% KH 2 PO 4 、0.05% MgSO 4  7H 2 O、100μg生物素、1000μg硫胺鹽酸鹽、2000μg鈣-泛酸、3000μg菸鹼醯胺、0.2g白胺酸、0.1g蘇胺酸、0.1g甲硫胺酸及5% CaCO 3 ，pH 7.0，以1L計)之250ml三角燒瓶中，且接著在震盪下在30℃及200rpm下培養72小時。
 Next, 1 ml of the seed culture was inoculated with 24 ml of manufacturing medium (4% glucose, 2% (NH  4  )  2  SO  4  , 2.5% soy protein, 5% corn impregnated solids, 0.3% urea, 0.1% KH  2  PO  4  , 0.05% MgSO  4  7H  2  O, 100 μg biotin, 1000 μg thiamine hydrochloride, 2000 μg calcium-pantothenic acid, 3000 μg nicotine guanamine, 0.2 g leucine, 0.1 g sulphate, 0.1 g methionine and 5 % CaCO  3  , pH 7.0, in 1 L of a 250 ml Erlenmeyer flask, and then incubated at 30 ° C and 200 rpm for 72 hours under shaking. 
 
 
   在培養後，藉由HPLC量測屍胺生產力。各菌株之細胞培養物中屍胺之濃度在下表7中給出。
 After incubation, cadaverine productivity was measured by HPLC. The concentration of cadaverine in the cell culture of each strain is given in Table 7 below.
 
 
 
 
 
 
 
 
 
 
 
 
 
   如表7中所顯示，引入ARCH_0271之麩胺酸棒狀桿菌突變型菌株中之屍胺產生增加超過17%。
 As shown in Table 7, the production of cadaverine in the mutant strain of Corynebacterium glutamicum introduced with ARCH_0271 increased by more than 17%.
 
 
 
 
   實例4.藉由將具有二胺輸出活性之蛋白引入至大腸桿菌中使二胺發酵 Example 4. Fermentation of a diamine by introducing a protein having diamine export activity into Escherichia coli 
 
 
 
 
   <4-1>藉由將ARCH_0271、QWA_00075或SMD_2351引入至W3110中來製備菌株 <4-1> Preparation of strain by introducing ARCH_0271, QWA_00075 or SMD_2351 into W3110 
 
 
 
   為了檢查溶血隱秘桿菌DSM 20595源性ARCH_0271、糞產鹼菌源性QWA_00075或嗜麥芽寡養單胞菌源性
SMD_2351之表現是否增加具有腐胺及屍胺之生物合成路徑的野生型大腸桿菌菌株W3110中之腐胺及屍胺產生，分別將基於棒狀桿菌及大腸桿菌穿梭載體之pDZTn-P(cj7)-ARCH_0271、pDZTn-P(cj7)-QWA_00075或pDZTn-P(cj7)-SMD_2351引入至W3110中。
 In order to check the cryptic bacterium, DSM 20595-derived ARCH_0271, basal bacterial-derived QWA_00075 or dermatophyte-derived bacterium
Whether the performance of SMD_2351 increases the production of putrescine and cadaverine in wild-type Escherichia coli strain W3110 with the biosynthetic pathway of putrescine and cadaverine, respectively, based on corynebacterium and Escherichia coli shuttle vector pDZTn-P(cj7)- ARCH_0271, pDZTn-P(cj7)-QWA_00075 or pDZTn-P(cj7)-SMD_2351 are introduced into W3110.
 
 
 
   2X TSS溶液(Epicentre)用於轉型至大腸桿菌中，且轉型體塗於含有用於菌落形成之卡那黴素(50μg/ml)的LB培養板(10g胰蛋白腖、5g酵母提取物、10g NaCl及2%瓊脂，以1L計)上且培養。因此形成之菌落分別指定為W3110 pDZTn-P(cj7)-ARCH_0271、W3110 pDZTn-P(cj7)-QWA_00075及W3110 pDZTn-P(cj7)-SMD_2351。
 2X TSS solution (Epicentre) was used for transformation into E. coli, and the transformation body was applied to LB plate containing kanamycin (50 μg/ml) for colony formation (10 g tryptone, 5 g yeast extract, 10 g NaCl) And 2% agar, in 1 L) and cultured. The colonies thus formed were designated as W3110 pDZTn-P(cj7)-ARCH_0271, W3110 pDZTn-P(cj7)-QWA_00075 and W3110 pDZTn-P(cj7)-SMD_2351, respectively.
 
 
 
 
   <4-2>比較引入ARCH_0271、QWA_00075或SMD_2351之大腸桿菌的二胺生產力 <4-2>Comparing the diamine productivity of Escherichia coli introduced with ARCH_0271, QWA_00075 or SMD_2351 
 
 
 
   檢查上文獲得之菌株之腐胺及屍胺生產力。
 The putrescine and cadaverine productivity of the strains obtained above were examined.
 
 
 
   詳言之，W3110及W3110 pDZTn-P(cj7)-ARCH_0271、W3110 pDZTn-P(cj7)-QWA_00075或W3110 pDZTn-P(cj7)-SMD_2351在LB固體培養基上在37℃下培養24小時。
 In particular, W3110 and W3110 pDZTn-P(cj7)-ARCH_0271, W3110 pDZTn-P(cj7)-QWA_00075 or W3110 pDZTn-P(cj7)-SMD_2351 were cultured on LB solid medium for 24 hours at 37 °C.
 
 
 
   接著，其中每一者在25ml滴定培養基(2g(NH 4 ) 2 PO 4 、6.75g KH 2 PO 4 、0.85g檸檬酸、0.7g MgSO 4 ．7H 2 O、0.5%(v/v)微量元素、10g葡萄糖、3g AMS及30g CaCO 3 ，以1L計)中在37℃下培養24小時。微量金屬溶液含有5M HCl：每1公升10g FeSO 4 ．7H 2 O、2.25g ZnSO 4 ．7H 2 O、1g CuSO 4 ．5H 2 O、0.5g MnSO 4 ．5H 2 O、0.23g 
Na 2 B 4 O 7 ．10H 2 O、2g CaCl 2 ．2H 2 O及0.1g(NH 4 ) 6 Mo 7 O 2 ．4H 2 O。
 Next, each of them was in 25 ml titration medium (2 g (NH  4  )  2  PO  4  , 6.75 g KH  2  PO  4  , 0.85 g citric acid, 0.7 g MgSO  4  .7H  2  O, 0.5% (v/v) trace elements 10 g of glucose, 3 g of AMS and 30 g of CaCO  3  were incubated at 37 ° C for 24 hours in 1 L. The trace metal solution contains 5M HCl: 10 g FeSO  4  per liter. 7H  2  O, 2.25g ZnSO  4  . 7H  2  O, 1g CuSO  4  . 5H  2  O, 0.5g MnSO  4  . 5H  2  O, 0.23g Na  2  B  4  O  7  . 10H  2  O, 2g CaCl  2  . 2H  2  O and 0.1g(NH  4  )  6  Mo  7  O  2  . 4H  2  O. 
 
 
   量測自各細胞培養物製造之腐胺及屍胺的濃度，且結果在下表8中給出。
 The concentrations of putrescine and cadaverine produced from each cell culture were measured, and the results are given in Table 8 below.
 
 
 
 
 
 
 
 
 
 
 
 
 
   如表8中所顯示，與親本菌株W3110相比，分別引入ARCH_0271、QWA_00075或SMD_2351之W3110 pDZTn-P(cj7)-ARCH_0271、W3110 pDZTn-P(cj7)-QWA_00075或W3110 pDZTn-P(cj7)-SMD_2351菌株中的腐胺及屍胺產生顯著增加。
 As shown in Table 8, compared with the parental strain W3110, W3110 pDZTn-P(cj7)-ARCH_0271, W3110 pDZTn-P(cj7)-QWA_00075 or W3110 pDZTn-P(cj7) of ARCH_0271, QWA_00075 or SMD_2351, respectively. There was a significant increase in putrescine and cadaverine in the SMD_2351 strain.
 
 
 
   亦即，已確認在細胞培養物中製造之二胺的量藉由增強與NCgl2522之胺基酸序列具有56%、41%或52%序列同源性的ARCH_0271、QWA_00075或SMD_2351蛋白之活性而顯著增加，表明輸出諸如腐胺及屍胺之二胺的能力可藉由增強CE2495或具有42%或更高的與之序列同源性的蛋白之活性而改良。
 That is, it has been confirmed that the amount of the diamine produced in the cell culture is remarkable by enhancing the activity of the ARCH_0271, QWA_00075 or SMD_2351 protein having 56%, 41% or 52% sequence homology with the amino acid sequence of NCgl2522. The increase indicates that the ability to export a diamine such as putrescine and cadaverine can be improved by enhancing the activity of CE2495 or a protein having a sequence homology of 42% or higher.
 
 
 
   因而，本發明的發明人證明藉由將ARCH_0271引入至具有腐胺合成路徑但具有降低之腐胺輸出活性的棒狀桿菌屬微生物KCCM11240P △NCgl2522之轉位子中而製備
之具有增強的ARCH_0271活性之麩胺酸棒狀桿菌具有增強之腐胺輸出活性，藉此以高產率製造腐胺。
 Thus, the inventors of the present invention have prepared by preparing ARCH_0271 into a transposon of the Corynebacterium microorganism KCCM11240P ΔNCgl2522 having a putrescine synthesis pathway but having reduced putrescine export activity.
Corynebacterium glutamicum having enhanced ARCH_0271 activity has enhanced putrescine export activity, thereby producing putrescine in high yield.
 
 
 
   因此，此菌株KCCM11240P △NCgl2522 Tn：P(cj7)-ARCH_0271指定為CC01-0758，且在2013年11月15日根據布達佩斯條約以寄存號KCCM11476P寄存於韓國微生物培養中心(KCCM)。
 Therefore, this strain KCCM11240P ΔNCgl2522 Tn:P(cj7)-ARCH_0271 was designated as CC01-0758, and was deposited with the Korean Microbiology Culture Center (KCCM) under the Budapest Treaty on November 15, 2013 under the registration number KCCM11476P.
 
 
 
 
   【生物材料寄存】 【Biomaterial Storage】 
 
 
 
   國內寄存資訊【請依寄存機構、日期、號碼順序註記】
 Domestic registration information [please note according to the registration authority, date, number order]
 
 
 
   1.財團法人食品工業發展研究所、2015.06.22、BCRC910684
 1. Research Institute of Food Industry Development, 2015.06.22, BCRC910684
 
 
 
   國外寄存資訊【請依寄存國家、機構、日期、號碼順序註記】
 Foreign deposit information [please note according to the country, organization, date, number order]
 
 
 
   1.韓國、韓國微生物培養中心、2013.11.15、KCCM11476P
 1. Korea, Korea Microbiology Center, 2013.11.15, KCCM11476P
 
 
 
 
   【無須寄存之生物材料】 [Biomaterials that do not need to be stored] 
 
 
 
   所屬技術領域中具有通常知識者易於獲得之生物材料
 Biomaterials readily available to those of ordinary skill in the art
 
 
 
   1. KCCM11016P 
 1. KCCM11016P
 
 
 
   2. KCCM11240P
 2. KCCM11240P
 
 
 
 
 
   <110> CJ第一製糖股份有限公司
 <110> CJ First Sugar Co., Ltd.
 
 
 
   <120> 用於製造屍胺之微生物及使用該微生物製造屍胺之方法
 <120> microorganism for producing cadaverine and method for producing cadaverine using the same
 
 
 
   <130> 105123237 
 <130> 105123237
 
 
 
   <150> KR 10-2014-0049871 
 <150> KR 10-2014-0049871
 
 
 
   <151> 2014-04-25 
 <151> 2014-04-25
 
 
 
   <160> 37 
 <160> 37
 
 
 
   <170> KopatentIn 2.0 
 <170> KopatentIn 2.0
 
 
 
   <210> 1 
 <210> 1
 
 
 
   <211> 25 
 <211> 25
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl2522-del-F1_BamHI 
 <223> NCgl2522-del-F1_BamHI
 
 
 
   <400> 1 
   <400> 1    
 
 
   <210> 2 
 <210> 2
 
 
 
   <211> 32 
 <211> 32
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl2522-del-R1_SalI 
 <223> NCgl2522-del-R1_SalI
 
 
 
   <400> 2 
   <400> 2    
 
 
   <210> 3 
 <210> 3
 
 
 
   <211> 29 
 <211> 29
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl2522-del-F2_SalI 
 <223> NCgl2522-del-F2_SalI
 
 
 
   <400> 3 
   <400> 3    
 
 
   <210> 4 
 <210> 4
 
 
 
   <211> 29 
 <211> 29
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl2522-del-R2_XbaI 
 <223> NCgl2522-del-R2_XbaI
 
 
 
   <400> 4 
   <400> 4    
 
 
   <210> 5 
 <210> 5
 
 
 
   <211> 1521 
 <211> 1521
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 溶血隱秘桿菌
 <213> Hemolytic bacillus
 
 
 
   <400> 5 
     <400> 5      
 
 
   <210> 6 
 <210> 6
 
 
 
   <211> 506 
 <211> 506
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 溶血隱秘桿菌
 <213> Hemolytic bacillus
 
 
 
   <400> 6 
       <400> 6        
 
 
   <210> 7 
 <210> 7
 
 
 
   <211> 1521 
 <211> 1521
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ARCH_0271(密碼子最佳化) 
 <223> ARCH_0271 (codon optimization)
 
 
 
   <400> 7 
     <400> 7      
 
 
   <210> 8 
 <210> 8
 
 
 
   <211> 40 
 <211> 40
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> CJ7-F 
 <223> CJ7-F
 
 
 
   <400> 8 
   <400> 8    
 
 
   <210> 9 
 <210> 9
 
 
 
   <211> 23 
 <211> 23
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> CJ7-R 
 <223> CJ7-R
 
 
 
   <400> 9 
   <400> 9    
 
 
   <210> 10 
 <210> 10
 
 
 
   <211> 35 
 <211> 35
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ARCH_0271-F 
 <223> ARCH_0271-F
 
 
 
   <400> 10 
   <400> 10    
 
 
   <210> 11 
 <210> 11
 
 
 
   <211> 34 
 <211> 34
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ARCH_0271-R 
 <223> ARCH_0271-R
 
 
 
   <400> 11 
   <400> 11    
 
 
   <210> 12 
 <210> 12
 
 
 
   <211> 203 
 <211> 203
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl1469(麩胺酸棒狀桿菌) 
 <223> NCgl1469 (Corynebacterium glutamicum)
 
 
 
   <400> 12 
   <400> 12    
 
 
   <210> 13 
 <210> 13
 
 
 
   <211> 203 
 <211> 203
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl1469(麩胺酸棒狀桿菌) 
 <223> NCgl1469 (Corynebacterium glutamicum)
 
 
 
   <400> 13 
   <400> 13    
 
 
   <210> 14
 <210> 14
 
 
 
   <211> 186 
 <211> 186
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> SpeG(大腸桿菌)W3110 
 <223> SpeG (E. coli) W3110
 
 
 
   <400> 14 
   <400> 14    
 
 
   <210> 15 
 <210> 15
 
 
 
   <211> 357 
 <211> 357
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ArgC 
 <223> ArgC
 
 
 
   <400> 15 
     <400> 15      
 
 
   <210> 16 
 <210> 16
 
 
 
   <211> 388 
 <211> 388
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ArgJ 
 <223> ArgJ
 
 
 
   <400> 16 
     <400> 16      
 
 
   <210> 17 
 <210> 17
 
 
 
   <211> 317 
 <211> 317
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ArgB 
 <223> ArgB
 
 
 
   <400> 17 
     <400> 17      
 
 
   <210> 18 
 <210> 18
 
 
 
   <211> 391 
 <211> 391
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ArgD 
 <223> ArgD
 
 
 
   <400> 18 
     <400> 18      
 
 
   <210> 19 
 <210> 19
 
 
 
   <211> 319 
 <211> 319
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ArgF 
 <223> ArgF
 
 
 
   <400> 19 
     <400> 19      
 
 
   <210> 20 
 <210> 20
 
 
 
   <211> 533 
 <211> 533
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> NCgl1221 
 <223> NCgl1221
 
 
 
   <400> 20 
       <400> 20        
 
 
   <210> 21 
 <210> 21
 
 
 
   <211> 711 
 <211> 711
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ODC(SpeC) 
 <223> ODC(SpeC)
 
 
 
   <400> 21 
         <400> 21          
 
 
   <210> 22 
 <210> 22
 
 
 
   <211> 1536 
 <211> 1536
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 糞產鹼菌糞亞種NCIB 8687 
 <213> Alkali sub-species NCIB 8687
 
 
 
   <400> 22 
     <400> 22      
 
 
   <210> 23 
 <210> 23
 
 
 
   <211> 511 
 <211> 511
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 糞產鹼菌糞亞種NCIB 8687 
 <213> Alkali sub-species NCIB 8687
 
 
 
   <400> 23 
     <400> 23      
 
 
   <210> 24 
 <210> 24
 
 
 
   <211> 1536 
 <211> 1536
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> QWA_00075(密碼子最佳化)
 <223> QWA_00075 (codon optimization)
 
 
 
   <400> 24 
   <400> 24    
 
 
   <210> 25 
 <210> 25
 
 
 
   <211> 1533 
 <211> 1533
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 嗜麥芽寡養單胞菌D457 
 <213> Stenotrophomonas maltophilia D457
 
 
 
   <400> 25 
   <400> 25    
 
 
   <210> 26 
 <210> 26
 
 
 
   <211> 510 
 <211> 510
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 嗜麥芽寡養單胞菌D457 
 <213> Stenotrophomonas maltophilia D457
 
 
 
   <400> 26 
     <400> 26      
 
 
   <210> 27 
 <210> 27
 
 
 
   <211> 1512 
 <211> 1512
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> SMD_2351(密碼子最佳化) 
 <223> SMD_2351 (codon optimization)
 
 
 
   <400> 27 
   <400> 27    
 
 
   <210> 28 
 <210> 28
 
 
 
   <211> 36 
 <211> 36
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> QWA_00075-F 
 <223> QWA_00075-F
 
 
 
   <400> 28 
   <400> 28    
 
 
   <210> 29 
 <210> 29
 
 
 
   <211> 37 
 <211> 37
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> QWA_00075-R 
 <223> QWA_00075-R
 
 
 
   <400> 29 
   <400> 29    
 
 
   <210> 30 
 <210> 30
 
 
 
   <211> 40 
 <211> 40
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> SMD_2351-F 
 <223> SMD_2351-F
 
 
 
   <400> 30 
   <400> 30    
 
 
   <210> 31 
 <210> 31
 
 
 
   <211> 39 
 <211> 39
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> SMD_2351-R 
 <223> SMD_2351-R
 
 
 
   <400> 31 
   <400> 31    
 
 
   <210> 32 
 <210> 32
 
 
 
   <211> 2142 
 <211> 2142
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 大腸桿菌
 <213> E. coli
 
 
 
   <400> 32 
     <400> 32      
 
 
   <210> 33 
 <210> 33
 
 
 
   <211> 713 
 <211> 713
 
 
 
   <212> PRT 
 <212> PRT
 
 
 
   <213> 大腸桿菌
 <213> E. coli
 
 
 
   <400> 33 
       <400> 33        
 
 
   <210> 34 
 <210> 34
 
 
 
   <211> 33 
 <211> 33
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> CJ7-F_KpnI 
 <223> CJ7-F_KpnI
 
 
 
   <400> 34 
   <400> 34    
 
 
   <210> 35 
 <210> 35
 
 
 
   <211> 32 
 <211> 32
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> CJ7-R-HindIII 
 <223> CJ7-R-HindIII
 
 
 
   <400> 35 
   <400> 35    
 
 
   <210> 36 
 <210> 36
 
 
 
   <211> 38 
 <211> 38
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ldcC-F_HindIII 
 <223> ldcC-F_HindIII
 
 
 
   <400> 36 
   <400> 36    
 
 
   <210> 37 
 <210> 37
 
 
 
   <211> 32 
 <211> 32
 
 
 
   <212> DNA 
 <212> DNA
 
 
 
   <213> 人工序列
 <213> Artificial sequence
 
 
 
   <220> 
 <220>
 
 
 
   <223> ldcC-R_XbaI 
 <223> ldcC-R_XbaI
 
 
 
   <400> 37 
   <400> 37    
 
 
 
 
 
 
 
 
 
 
 
